US20070167907A1 - Needle free hypodermic injector and ampule for intradermal, subcutaneous and intramuscular injection - Google Patents
Needle free hypodermic injector and ampule for intradermal, subcutaneous and intramuscular injection Download PDFInfo
- Publication number
- US20070167907A1 US20070167907A1 US10/555,742 US55574204A US2007167907A1 US 20070167907 A1 US20070167907 A1 US 20070167907A1 US 55574204 A US55574204 A US 55574204A US 2007167907 A1 US2007167907 A1 US 2007167907A1
- Authority
- US
- United States
- Prior art keywords
- ampule
- drive rod
- suction
- injector
- housing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/2006—Having specific accessories
- A61M2005/202—Having specific accessories cocking means, e.g. to bias the main drive spring of an injector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/2073—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically preventing premature release, e.g. by making use of a safety lock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/204—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically connected to external reservoirs for multiple refilling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum
Definitions
- This invention relates to a needle free, impact impulse injector device and disposable, single use, fillable or pre-filled, ampules therefor that are capable of delivering intradermal, (ID), subcutaneous (SUB-Q) and intramuscular (IM) injections in human or animal tissue by means of a thin high pressure liquid jet stream of sufficient velocity to penetrate the tissue of the recipient.
- the injector deposits medicament intradermally, or subcutaneously, or intramuscularly, utilizing the single use, disposable, medicament ampules that are designed to provide interfaces to the activation device, allowing easy installation by hand or mechanically from a multiple ampule dispensing apparatus, and providing exact positioning and sealing to the activation device structure.
- the ampules further contain features that induce a vacuum to stretch the skin, keeping the skin precisely aligned with the jet orifice for the short duration of the injection.
- the ampule's orifice has different offset variations for ID, SUB-Q or IM injections.
- Ampules and injectors may also be adjusted for variations in medicament viscosity as required by various classes of medicaments including providing multiple orifices in the ampule for injection of larger doses or wider patterns.
- the injector device is manually, pneumatically and/or electrically or electromagnetically activated and provides interface features for mounting the ampules, and features rendering it possible for the impulse force to inject the medicament at any angle from horizontal to vertical relative to the skin surface as well as at skew angles, as the activation process is performed.
- the activation device provides safety interlock features which prevent the impulse force from being inadvertently activated, except when the ampule is properly interfaced with the skin surface.
- the injector provides the operator with a comfortable, light weight device that allows the operator to quickly and easily load an ampule, properly position the ampule on the skin surface, activate the impulse force, inject the medicament and reset the activation device.
- a needle-free ampule which discharges a pre-measured quantity of fluid medicament in a thin jet at a sufficient velocity to penetrate the tissue of both humans and animals to be treated or vaccinated at any angle from horizontal to vertical.
- This invention utilizes a single-use, disposable medicament ampule having the capability to apply a vacuum to stretch and properly hold the skin prior to injecting a medicament into the tissue, and a manually, pneumatically, electrically or electromagnetically operated activation injector device.
- the ampule and the injector are truly unique designs constructed with materials presently being used in the medical industry and designed to minimize effort, be easy to handle and operate.
- the size and shape selected also minimize weight. The age, size of hands, hand strength, skin type and thickness, as well as visibility of operations, were very important considerations.
- Langerhans cells are dendritic cells generally located in the upper spinosum layer of the skin. These cells are known to participate in cutaneous immune responses and migrate from the skin to the lymph nodes. They possess surface receptors common to macrophages and function as antigen presenting cells to T and B lymphocytes. The Langerhans cells serve to fix and process cutaneous antigens and, as such, are the first immune cells to arrive at sites of inflammation. For this reason, Langerhans cells are of particular interest in immune system studies with respect to enhancing vaccine development and creating treatments for auto-immune diseases and anti-rejection therapies.
- Needleless injectors have been used as an alternative to hypodermic needle type injectors for delivering drugs, vaccines, local anaesthetics and other fluids into the human or animal tissue.
- the medicament is discharged at high velocity so as to first penetrate the epidermis and thereafter be deposited in the tissues of the subject.
- An alternative method is to press the discharge nozzle onto the skin and force the fluid at very high pressure through the epidermis.
- Such prior art devices result in substandard and painful injections because of this blasting action and the inability to address the variables of flow control once the skin is penetrated. They are also deficient with respect to being able to provide the force necessary to penetrate the stratum corneum while restricting medicament delivery to the intradermal area generally and, specifically, the upper layers of the skin.
- Prior art devices generally employ spring loaded piston pumps to withdraw fluid from a reservoir. At the end of the piston retracting stroke, the piston is disengaged from the retracting mechanism and reverses direction to pressurize the fluid for ejection from the delivery nozzle.
- the fluid is contained in an adjacent container or vessel within the device and the fluid is fed into the nozzle under pressure and discharged under pressure through the delivery nozzle.
- the piston is driven on the discharge stroke by gas or an electric motor instead of a spring. In most of these devices the discharge orifice must be placed firmly on the skin to make direct contact of the nozzle with the epidermis.
- the orifice is pressed firmly into the epidermis by the operator at an angle that is normal to the skin surface, usually perpendicular to the plane of the skin, so as to stretch the epidermis at the point of contact and thereby increase the ability of the injection to penetrate the stretched tissue at the point of contact.
- the pressing of the orifice into the epidermis is a variable that is dependent on the device's operator and the ability of the recipients to tolerate the device being pressed against their anatomy.
- the use of existing devices results in loss of medicament at the nozzle entry point, poor injections on account of the recipient's movements or the operator's inexperience and receipt of the injection at an angle that either does not penetrate or penetrates too much for placement and dispersal of the medicament at the correct depth and layer of tissue.
- premature operations are common, as well as relative movement between the epidermis and orifice which can cause tearing of the skin during injection, resulting in pain and poor transfer of the medicament to the recipient.
- the epidermis will deform away from the orifice and the injection fluid will leak away from the point of entry.
- the devices attempt to stretch the epidermis by deforming over the discharge orifice. In all of these conditions, the success of the injection procedure depends and rests on the ability of the operator to consistently perform, using the device to get an acceptable discharge and penetration of the epidermis.
- U.S. Pat. No. 3,859,996, Mizzy discloses a controlled leak method to ensure that the injector orifice is placed correctly at the required pressure on the subject's skin and at the correct attitude to the skin.
- controlled leak is sealed off by contact pressure on the subject's skin and the pressure within the injector control circuit rises until a pressure sensitive pilot valve opens to admit high pressure gas to drive the piston and inject the medicament.
- This use of valving and pressure gas renders the device complex to manufacture and use and does not apply to the present invention.
- WO Patent 82/02835, Cohen and Ep-A-347190, Finger disclose a method to improve the seal between the orifice and the skin and prevent relative movement between each.
- This method is to employ a vacuum device to suck the epidermis directly and firmly onto the discharge orifice.
- the discharge orifice is positioned normal to the skin surface in order to suck the epidermis into the orifice.
- This method for injection of the medicament into the skin and the injector mechanism are different and do not apply to the present invention because of its unique ampule design.
- U.S. Pat. No. 3,859,996, Mizzy further discloses a pressure sensitive sleeve on the injector which is placed on the subject and whereby operation of the injector is prevented from operating until the correct contact pressure between orifice and the skin is achieved.
- the basic aim is to stretch the epidermis over the discharge orifice and apply the pressurized medicament at a rate which is higher than the rate at which the epidermis will deform away from the orifice. This method of stretching the skin on to the orifice, together with the arrangements of the mechanism are totally different from the present invention and, consequently, do not apply.
- U.S. Pat. No. 5,480,381, T. Weston discloses a means of pressuring the medicament at a sufficiently high rate to pierce the epidermis before it has time to deform away from the orifice.
- the device directly senses that the pressure of the discharge orifice on the subject's epidermis is at a predetermined value to permit operation of the injector.
- the device is based on a cam and cam follower mechanism for mechanical sequencing, and contains a chamber provided with a liquid outlet for expelling the liquid, and an impact member, to dispell the liquid.
- the sequencing and cam operation are driven by an electric motor gear-box, and along with the cam action sequencing and adjustable pressure sensing do not apply to the present invention.
- U.S. Pat. No. 5,891,086, T. Weston describes a needleless injector that contains a chamber that is pre-filled with a pressurized gas which exerts a constant force on an impact member in order to strike components of a cartridge and expell a dose of medicament.
- This device contains an adjustment knob which sets the dose and the impact gap, and uses direct contact pressure sensing to initiate the injection. This use of contact pressure sensing, the need for constant adjustment and the use of pressurized gas to implement the injection process do not apply to the present invention.
- the subject of the present invention represents an innovative approach to hypodermic needle-free injections, either Intradermal (ID), Subcutaneous (SUB-Q) or Intramuscular (IM), providing a process and a mechanization which contains disposable filled or prefilled medicament ampules and a manuallyor automatically operated activation device.
- ID Intradermal
- SUV-Q Subcutaneous
- IM Intramuscular
- the injection uses horizontal impact impulse jet pressure, and thus it spreads the particles over a larger area than using a needle syringe, decreases the local pressure in the tissue, and eliminates leakage of the fluid from the opening in the tissue thereby reducing the possibility of spreading infections.
- the apparatus is capable of injection at any angle between horizontal and vertical in addition to laterally relative to the center line of the ampule, depending on the specific conditions of the medicament, injection site, etc.
- a unique feature of this invention is that the medicament is driven out of the ampule that holds it with a known and controlled impact impulse force.
- a further innovation of the present invention is the process of the stretching of the skin, which increases permeability thus reducing the amount of energy required to inject fluid into a tissue, in conjunction with the injecting of the fluid horizontally to vertically and/or laterally into the skin which allows controlled positioning of the tissue for intradermal, subcutaneous or intramuscular injections. Also significant is the introduction of a safety feature built into the injector that will not allow operation until the skin is properly positioned.
- the ampule interfaces with the injector allowing installation by hand or mechanical means, and has features for the application a vacuum produced by the operation of the injector that stretches and properly holds the skin, precisely aligned with the jet orifice during the short duration of the injection.
- the activation device provides the interface for mounting the ampule and for delivering the impact impulse force required to inject the medicament as the activation process is performed.
- Each ampule body includes a see through window with external gradient markers to indicate the quantity of medicament the ampule contains.
- the injector operates in like manner as the primary embodiment, with the exception that certain functions and sequence operating components utilize external air pressure for activation.
- the handle has been replaced with a finger operated trigger, and return functions are all air driven.
- the pneumatic operation can be achieved using an electronic solenoid with power provided by a battery pack that may be part of or separate from the injector.
- the ampule configuration in both embodiments is identical and its attachment to the injector and filling procedure are the same. Inasmuch as each injector embodiment utilizes the same ampule, then each provides a means for administering either Intradermal (ID), Subcutaneous (SUB-Q) or Intramuscular (IM) injections.
- ID Intradermal
- SUV-Q Subcutaneous
- IM Intramuscular
- a still further embodiment of the present invention provides an injector that is adapted to receive a multiple ampule assembly and a multiple ampule assembly therefor.
- the components and operation of the injector are substantially identical to those of the other embodiments except that the front end of the injector is modified to receive a rotatable, multiple ampule assembly, which assembly has a plurality of ampules arranged in a cylindrical cartridge.
- the cartridge is rotatable on the forward end of the injector so as to bring each ampule thereof into registration with the suction and injection means of the injector.
- the present invention overcomes these deficiencies by the combination of the injector device and the ampule used therewith.
- the ampule is a key element of the system as it is the part which holds the medicament to be injected and interfaces with both the injector and the patient's skin surface to apply the suction generated by the injector in order to draw the skin tight for proper injection.
- the ampule further interfaces with the injector to provide proper functioning of the safety interlock since release of the interlock requires establishing a full suction on the system which cannot be achieved without the ampule.
- the ampule and the injector combination of the present invention it is now possible to achieve needle-less injection of medicament intradermally, subcutaneously and intramuscularly at any angle relative to the skin surface.
- the ampule and injector combination of the present invention are capable of achieving the shallow intradermal injection necessary to accurately and reliably deliver medicament to the Langerhans cells in the upper spinosum layer of the skin.
- the present invention provides a needle free hypodermic injector comprising a hand manipulatable elongate housing, an impact impulse injection mechanism within the housing, a suction generating means within the housing and cooperable with the impact impulse injection mechanism, a safety interlock mechanism, at least one medicament containing ampule cooperable with the impact impulse injection mechanism and the suction generating means and having a jet orifice through which medicament is injectable through a skin surface in response to an impulse placed on the medicament by the impact impulse injection mechanism, and means to receive and hold the ampule on the injector in registration with the impact impulse injection mechanism and in communication with the suction generating means; whereby the injector is adapted to expel the medicament from the ampule in a jet stream of sufficient velocity to penetrate skin tissue held against the orifice by the suction generating means and to deposit the medicament intradermally, subcutaneously or intramuscularly based on the position and angle of the jet orifice.
- the present invention further provides an ampule for a needle free hypodermic injector, wherein the ampule comprises an elongated body having a forward end, a rearward end, a substantially planar upper surface and a lower surface having a downward offset between the forward end and the rearward end, this offset providing a forward facing step face, a horizontally disposed bore within the body extending from the rearward end of the body to a point substantially adjacent to the step face, the bore being open at the rearward end and having a sealing plunger disposed therein to be driven by the impact impulse mechanism, the bore further having a jet orifice extending through the step face, whereby the bore is capable of holding a quantity of medicament injectable through a skin surface held against the orifice in response to the plunger being driven forward in the bore by the impact impulse injection mechanism.
- the present invention still further provides a needle free hypodermic injector wherein the ampule further comprises at least one suction port extending vertically through the body from the upper surface to the lower surface at a point forward of the step face, the suction port being in fluid communication with the suction generating means whereby a suction generated by the suction generating means is applicable to the skin surface through the port to draw the skin surface upward against the lower surface of the ampule and the jet orifice prior to injection thereby stretching the skin to improve its porosity to the jet of medicament and, depending on the angle and placement of the orifice, to direct the jet of medicament intradermally, subcutaneously or intramuscularly.
- the present invention still further provides a needle free hypodermic injector comprising an injector assembly and at least one medicament containing ampule removably attachable to the injector assembly, the injector assembly comprising an elongated hand manipulatable housing, the housing comprising a main body portion containing a mechanical impact impulse means comprising a drive rod linearly reciprocatable within the housing between a cocked position and an injection position, a compressible drive spring linearly concentric about a rear portion of the drive rod, the spring being confined between a stationary abutment within the housing and a projection substantially midway along the drive rod whereby rearward displacement of the drive rod compresses the spring, a latch mechanism cooperating with the projection to releasably hold the drive rod in a cocked position wherein the spring is compressed, a release means to release the latch mechanism when injection is desired, and a cocking means cooperating with the drive rod and operable to draw the drive rod in a rearward direction to the cocked position thereby compressing the
- the injector further comprises a forward nose portion adapted to removably receive at least one ampule and having detent means to releasably secure the ampule to the injector assembly when the impact impulse mechanism is in the cocked position, the at least one ampule comprising a body having a forward end and a rearward end, a substantially planar upper surface and a stepped lower surface having a forward facing step face therein, the body having formed therein behind the step face a horizontally disposed substantially cylindrical medicament chamber open at the rearward end and narrowing to a jet orifice in the step face, the chamber being sized and positioned to receive a forward end of the drive rod when the ampule is secured to the injector assembly and the latch mechanism is released, the chamber further containing a sealing plunger providing a means to retain medicament in the chamber, the plunger adapted to be engaged by the drive rod upon release of the latch mechanism, whereby the drive rod drives the plunger forward within the horizontally disposed chamber forcing the medicament under pressure through the jet orifice
- the needle free hypodermic injector of the present invention further comprises at least one suction port vertically disposed through the ampule body forward of the jet orifice, a suction generating means disposed in the main body portion of the housing and suction conduits within the housing and the nose portion providing fluid communication between the suction generating means and the at least one suction port whereby suction generated by the suction generating means is conveyed to the at least one suction port of the ampule, the suction serving to draw the skin surface against the ampule and the orifice prior to injection.
- the lower surface of the ampule immediately surrounding the suction port be concave thereby forming a slight depression into which the skin is drawn by the suction.
- the injector does not touch the skin tissue around the injection, it can be submerged in alcohol for sterilization, if desired, since all materials are presently being used in the medical industry, and are compatible with all current sterilization methods.
- FIG. 1 is a top view of the needle-free injector of the present invention.
- FIG. 2 is a side view of the needle-free injector in a manual configuration.
- FIG. 3 is a longitudinal cross section of the needle-free injector of FIG. 2 prior to injection.
- FIG. 4 is a cross section of the needle-free injector of FIG. 2 after injection.
- FIG. 5 is a view of the end cap of the needle-free injector of FIG. 2 .
- FIG. 6 is a vertical cross section through the injector of FIG. 2 at the vacuum piston.
- FIG. 7 is a partial longitudinal cross section of the injector of FIG. 2 through the suction manifold.
- FIG. 8 is a longitudinal cross section of an alternative embodiment of the injector configured for operation by air pressure prior to injection.
- FIG. 9 is a longitudinal cross section of the alternative embodiment of the injector configured for operation by air pressure after injection.
- FIG. 10A is a side view of the return piston housing of the alternative embodiment of the injector of FIG. 8 .
- FIG. 10B is an end view of the return piston housing of the alternative embodiment of the injector of FIG. 8 .
- FIG. 11 is a side view of an ampule according to the present invention.
- FIG. 12 is a top view of an ampule according to the present invention.
- FIG. 13 is a longitudinal cross section through the ampule of FIG. 11 .
- FIG. 14 is a view of an ampule in an adaptor for filing.
- FIG. 15 is a top view of an alternative embodiment of an ampule according to the present invention having a stopper for filing via a hypodermic syringe.
- FIG. 16 is a longitudinal cross section of the ampule of FIG. 15 with protective coverings in place.
- FIG. 17 is a longitudinal cross section of the ampule of FIG. 15 being filled.
- FIG. 18 is a longitudinal cross section of the ampule of FIG. 15 filled with medicament and sealed for use.
- FIG. 19 is a side view of a multiple ampule unit injector.
- FIG. 20 is a longitudinal cross section of the multiple ampule unit injector of FIG. 19 .
- FIG. 21 is a detailed cross section of the forward end of the multiple ampule unit injector of FIG. 19 .
- FIG. 22 is a vertical cross section of the multiple ampule unit injector of FIG. 19 through the vacuum ports of the ampule assembly.
- FIG. 23 is a view of the ampule assembly showing adjacent ampules.
- FIG. 24 is a view showing an intradermal injection ampule in use.
- FIG. 25 is a close-up view of the intradermal injection.
- FIG. 26 is a view showing a subcutaneous injection ampule in use.
- FIG. 27 is a close-up view of the subcutaneous injection.
- This invention relates to a device and method for a needle-less jet injection of a medicament into the skin of a human or animal from a disposable tillable or pre-filled ampule that uses a vacuum to stretch the recipient's skin in order to increase its permeability for injection and which, in turn, reduces the amount of energy required to inject the medicament into the skin tissue.
- the vacuum further positions the skin correctly for injection of the medicament.
- the method uses the device to inject a premeasured dose of medicament by means of a high pressure jet stream of sufficient velocity to penetrate human or animal epidermis, depositing the medicament intradermally, or subcutaneously, or intramuscularly, depending on the offset and angle of the disposable ampule's orifice to the epidermis and the impact impulse force.
- Another novelty of the process consists in injecting the medicament horizontally, or any other desired angle, into the skin from a single use ampule, spreading the particles over a larger area than when using a needle syringe.
- the method provides decreased local pressure in the skin tissue at the point of injection, thus reducing local pain, minimizing tissue damage, eliminating leakage of fluid at the injection opening, and reducing the possibility of spreading infections, while providing a safety device to prevent inadvertent triggering of the injector.
- the injector assembly 20 shown in FIG. 1 comprises a molded housing 21 containing the injector mechanism that is activated by a release button 23 . Activation of the injector 20 disperses the medicament 31 contained in ampule 25 shown in FIG. 2 .
- the ampule 25 is retained on the injector 21 by a retainer clamp 22 attached to the forward end of the injector 20 and by an insert fairing 74 on the underside of the injector 20 at the opposite end of the ampule 25 .
- the principal embodiment of the injector 20 is manually operated and is cocked for release of the medicament by rotation of a handle 30 , around a shaft 56 .
- the handle 30 is provided with shaped hand grips 29 for ease of operation.
- the handle 30 rotates at handle pivot 24 .
- FIG. 3 shows a cross section view of the injector 20 prior to activation of the mechanism for injection.
- the mechanism within the housing 21 comprises a piston 35 adapted to create a vacuum for stretching the recipient's skin at the injection site immediately prior to injection and a release mechanism to pressure drive the medicament into the skin tissue.
- the mechanism within the housing 21 of the injector 20 also comprises a compression drive spring 42 which provides the force that drives one end of a drive rod 43 into the ampule 25 that contains the medicament.
- the drive rod 43 has a retention ring 59 at the opposite end which cooperates with a means for locking the drive rod 43 with the compression drive spring 42 compressed.
- a projecting ring 120 substantially midway along drive rod 43 provides a surface on the drive rod 43 for the compression spring 42 to push against.
- the opposite end of the compression drive spring 42 abuts against an annular surface 123 at the end of drive spring chamber 128 within housing 21 .
- the mechanism of the injector 20 is cocked by rotation of the handle 30 to the position of FIG. 4 , which pulls slide frame 45 , via extension link 40 , forward so that drive rod latch 48 snares retention ring 59 on the end of drive spring drive rod 43 .
- latch 48 slides along spring ramp 50 and is rotated downward to engage the forward surface of retention ring 59 .
- the drive rod latch 48 is preloaded to a release position by a torsion spring 53 at the pivot point of latch 48 and side frame 45 .
- Contact of latch 48 with spring ramp 50 pushes latch 48 downward against the torsion spring load to the locking position that captures the drive rod retention ring 59 .
- Spring ramp 50 is preferably retained in the housing 21 by two pins 51 .
- the drive rod latch 48 is supported by the slide frame 45 and pivots around a pin joint 52 in the upright supports of the slide frame 45 and is retained in the slide frame with a horizontal pin 58 that also retains a connector link 47 .
- the slide frame 45 has a horizontal lower leg that slides in and is guided by a machined-in groove 122 in the housing 21 .
- the horizontal lower leg of side frame 45 is provided with an end termination pivot point 60 for pivoting attachment of extension link 40 .
- the handle 30 itself is attached to the injector assembly housing 21 and rotates around the pivot 24 .
- the injector handle 30 attached to the outside of the housing 21 comprises two contoured legs that straddle the housing 21 with and each leg being attached to the pivot point 24 on either side of the housing structure by capture pin 58 .
- the free end of injector handle 31 is formed or molded to provide finger or hand grip 29 .
- the handle 30 is of extended length in order to provide sufficient leverage for compressing the drive rod compression spring 42 .
- Extension link 40 can rotate around its handle attachment point 41 permitting the extension link 40 to rotate when the handle 30 is also rotated.
- a similar pivot connection to the slide frame 45 at pin joint 60 permits extension link 40 to pivot relative to slide frame 45 so that when the handle 30 is rotated down or up the extension link 40 pushes or pulls on the slide frame 45 .
- the slide frame 45 has a second function.
- the injector 20 creates a vacuum at this contact point of the ampule 25 and the recipient's skin.
- the slide frame 45 has attached to it a second connector link 47 extending rearward from latch 48 to engage vacuum piston 35 in the rear of housing 21 . The slide frame 45 movement in the rearward direction compresses the compression spring 42 and pulls the drive rod 43 to the cocked position.
- connector link 47 which is attached to the upright supports of the slide frame 45 at one end and pin joint 51 by capture pin 58 at the opposite end is attached to piston extension 46 by rod latch pivot pin 54 , pulls piston 35 rearward within cylinder 123 which is milled in the rear of housing 21 .
- the piston 35 provides the vacuum for the injector 20 , when applied to the recipient's skin, to pull and stretch the skin tight against the suction ports 63 , in the ampule 25 , which serves to position the outlet orifice 66 correctly for injection of the medicament.
- the vacuum system includes a safety device to prevent inadvertent triggering of the injector 20 without first obtaining a good vacuum seal of the ampule 25 to the skin.
- the safety device comprises a small interlock piston rod 36 , which is adapted to engage and disengage a release catch 44 in response to a vacuum generated by piston 35 .
- Interlock piston rod 36 reciprocates within channel 125 and is provided with a small piston 126 on its rearward end which is located within a small cylinder 127 communicating with the cylinder 123 of vacuum piston 35 .
- the piston 35 has an O-ring seal 34 that ensures that the piston can produce a vacuum within cylinder 123 for actuation of the small interlock piston rod 36 .
- the vacuum provided acts on small piston 126 to position the small interlock piston rod 36 to engage or disengage the release arm 55 , thereby locking it in a non-release, or unlocking it in a release position.
- the release arm 55 is able to rotate between the two operating positions around a pivot pin 54 that interfaces with the injector housing structure 21 and is biased to the lock position by torsion spring 33 on pivot pin 54 .
- a pair of connector links 47 straddle the vacuum piston 35 and are connected to it by piston extension 46 . Movement of the slide frame 45 drives the vacuum piston 35 , and the vacuum created is ported to the ampule 25 through a suction tube 71 .
- the injector is provided with a release button 23 which, when pressed, rotates the release arm 55 about pivot pin 54 . As the release arm 55 engages release catch 44 , rotation of release arm 55 downward causes release catch 44 to pivot upward, releasing drive rod 43 which is then forced forward by drive spring 42 so that the forward end of drive rod 43 enters ampule 25 . Release catch 44 rotates around latch pin 58 against torsion spring 53 .
- the release button 23 is installed in the injector housing 21 structure so that when pushed inward it contacts the release arm 55 acting as a cam and causing the release arm 55 to rotate downward and, in turn, lift the release catch 43 , that locks the compression spring 42 in its loaded compression position.
- the release button 23 is retained in the injector housing 21 flush with the housing's outer surface to prevent inadvertent actuation until required by the operating procedure, and is retained in the housing structure with a retention snap ring 32 .
- release catch 44 includes torsion spring 53 which is tensioned to hold release catch 44 in the lock position to hold the drive rod 43 against the compressed compression spring 42 .
- An angular end surface of release catch 44 provides a means for contact with a corresponding angular end surface of the release arm 55 so that, during the release function, the release catch 44 is pivoted upward around the pivot point provided by the latch pin 58 that engages the housing 21 structure as release arm 55 is pushed downward by button 23 .
- FIG. 4 shows a cross section view of the injector 20 after injection of the medicament and with the handle 30 rotated away from the housing.
- a spring ramp 50 forces the drive rod latch down to engage and lock on to the projecting retention ring 59 .
- the spring ramp is retained by two roll pins 51 .
- the latch 48 has a torsion spring 53 that is retained by the pin 58 , and drives the latch to the release position around pivot pin 52 .
- piston 35 has an annular O-ring seal 34 contained within an annular groove in the surface of piston 35 and which engages the wall of cylinder 123 .
- the vacuum generated by piston 35 is conveyed to the ampule 25 by suction passages 73 and vacuum tube 71 which is provided with a seal 70 at the point of interface with the ampule 25 to ensure the function of suction of the skin at ampule contact for efficient injection of the medicament by the injector.
- the injection release button's 23 lower surface cams down the release arm 55 and forces the release catch 44 upward.
- the release arm 55 rotates around pivot point 57 that holds the pin 54 and torsion spring 33 .
- the injector 20 contains a locking feature that prevents the possible release of the drive rod 43 .
- the handle 30 When the handle 30 is rotated, movement of the vacuum piston 35 within cylinder 123 creates pressure or vacuum against small piston 126 resulting in reciprocation of interlock piston rod 36 between the locked and unlocked positions. Pressure generated within cylinder 123 by piston 35 as handle 30 is rotated downward to engage drive rod latch 48 with retention ring 59 , pushes interlock piston rod 36 forward into the locked position with release arm 55 .
- the small piston 126 on interlock piston rod 36 is provided with an O-ring 37 to maintain the vacuum between large piston 35 and the interlock piston rod 36 .
- a suction port A 38 shown in FIG. 7 , for the transfer of vaccum from cylinder 123 to the ampule 25 .
- the interlock piston rod 36 is retained with a retainer ring 39 in small cylinder 127 .
- FIG. 4 also indicates the surface 69 that contacts the recipient's skin for injection of the medicament.
- the ampule 25 is expendable and can be easily installed on the injector assembly by rotating the retainer clamp 22 that is detented 26 , on to the housing 21 of the injector assembly.
- FIG. 5 shows an end view of the injector assembly and end cap 28 , with its attachment screws 76 .
- FIG. 6 provides a cross section view of said housing 21 , and indicates the two legs of the slide frame 45 as they straddle the vacuum piston 35 .
- FIG. 7 provides a sectional view through the housing, and shows the routing and passages through the suction manifold 72 .
- the manifold suction passages 73 supply the necessary vacuum for extracting the interlock piston rod 36 from release arm 55 with a small incoming vacuum for movement of the piston rod 36 into the injector assembly 20 .
- the suction manifold system is comprised of machined vacuum ports 129 in the housing structure to receive the vacuum pressure from the vacuum piston 35 and conduct a vacuum through ported suction passages 73 in the structure within the vacuum piston chamber 123 to the interlock piston chamber 127 and to the suction tubes 71 that interface with the ampule 25 the suction passages are sequentially opened and closed by positioning of the interlock piston 126 , and a pair of suction tubes that conduct the suction from the machined-in structure suction passages to the suction ports 63 in the ampule 25 .
- the injector 20 operating sequence starts by squeezing the handle 30 without an ampule 25 being installed. This causes the drive rod 43 to be pulled back and latched in the cocked position with the compression drive spring 42 compressed between projecting ring 120 and annular abutment surface 124 at the rear end of spring chamber 128 .
- Drive rod latch 48 which catches and draws drive rod 43 back, is spring loaded up and away from drive rod 43 and is only in position to grab the drive rod 43 when in the full forward position due to spring ramp 50 . If drive rod 43 has been released, latch 48 will catch the lip of drive rod retention ring 59 and will pull the drive rod 43 back as the handle 30 is squeezed.
- Latch 48 is provided with a notch 125 in its underside for this purpose.
- drive rod retention ring 59 has a small concave depression in the forward face to engage the notch 125 of drive rod latch 48 and hold it in place while the handle 30 is squeezed.
- drive rod latch 48 Upon full retraction of drive rod 43 and engagement of projecting ring 120 with release catch 44 , drive rod latch 48 disengages from retention ring 59 and is pivoted upward by torsion spring 53 to clear retention ring 59 when drive rod 43 is released.
- ampule 25 is slid into position and ampule retainer clamp 22 is tightened which brings ampule 25 up against seals 70 in the bottom of the injector nose with the ampule locking tabs 61 engaged with the injector structure.
- the injector 20 is then placed into position with the ampule 25 on the patient's skin and the handle 30 extended.
- the handle 30 is squeezed again. Since the drive rod 43 is already back in the cocked position, the drive rod retention ring 59 will not be in position for the drive rod latch 48 to catch on when the handle 30 is extended and squeezed again.
- the vacuum piston 35 creates a vacuum in cylinder 123 which is conveyed to suction ports 63 in ampule 25 by suction passages 73 and suction tubes 71 .
- This vacuum stretches the skin tight against the ampule 25 and, when a good seal to the skin is obtained, will cause the interlock piston rod 36 to retract from interlock hole 80 in release arm 55 , thereby releasing button 23 for operation.
- the release button 23 is pressed thereby camming release arm 55 downward which lifts release catch 44 to disengage from projecting ring 120 thus allowing spring 42 to push drive rod 43 into the ampule 25 providing the force necessary to eject the medicament 31 from the ampule 25 through orifice 66 .
- FIG. 8 and FIG. 9 A second embodiment of the injector assembly is shown in cross section in FIG. 8 and FIG. 9 .
- the former embodiment utilizes manual operation by the rotation of a hand operated handle 30
- this embodiment utilizes external air supplied power for some of its functions.
- the primary embodiment utilizes the manual extending downward and retracting of the handle to actuate a large piston 35 to create a vacuum that is utilized for ensuring that the recipient's skin is in direct contact with the injector's injection orifice 66 .
- This manual mechanism also actuates a means for preventing accidental activation of the injector and a means for compressing the impulse drive spring 42 to a lock position, ready for release by the operator pushing downward on the activation button 23 .
- an external source of pressurized air provides a means whereby the mechanical operations of cocking the drive spring 42 and drive rod 43 , generating a vacuum and activating and deactivating the locking safety mechanism are substantially automated so as to occur in response to movement of a trigger assembly 89 .
- the vacuum assist is achieved by the operation of a valve 100 that is controlled by a trigger assembly 89 .
- Movement of the trigger one way opens the valve for pressure to travel up to a large return piston 83 in extension housing 102 on the rear end of injector housing 21 , that pulls back on the vacuum piston 35 to create a vacuum and initiate the same functions achieved by the previous handle movement, connection of the return piston 83 to the vacuum piston 35 being by means of connecting rod 82 passing through the end wall of extension housing 102 .
- Activation of the trigger in the opposite direction closes off the outside pressure source and, in turn, shuts down the vacuum assist function provided by the return piston 83 .
- FIG. 8 and FIG. 9 show this new embodiment in two positions during the injection operation.
- This embodiment of the needle-free jet injector utilizes external air pressure for activating and sequencing the injector components.
- the injector 20 is provided with a trigger assembly 89 that is operated by the operator's finger for initiation and movement of an air valve 100 in the injector 20 , that opens and blocks externally supplied air pressure from exterior source entering through fitting 49 to a large return piston 83 that is, in turn, connected to the vacuum piston 35 by connecting rod 82 .
- the vacuum piston 35 functions as described in connection with the previous embodiment and provides the vacuum for interlock functions of the release button 23 and the release catch 44 to initiate injection of the medicament.
- the vacuum piston 35 is moved by the return piston 83 to create a vacuum at the interface contact surface of the recipient's skin and the ampule 25 containing the medicament
- the trigger assembly 89 is operated by the injector operator's finger applying a squeezing motion to move the trigger 89 upward, toward the injector activation frame 87 thereby causing the trigger assembly 89 to push against a push rod 90 which actuates a valve 100 to sequence air pressure to enter the injector from the outside air supply through source fitting 49 .
- the push rod 90 travels fore and aft in a machined support fitting 95 that is attached to the underside of the injector assembly and is retained within the support fitting 95 by a threaded bushing 105 at the end adjacent to the trigger 89 which provides a means for sealing and retention of the air pressure within the support fitting 95 .
- An O-ring seal 92 is captured between the bushing 105 and the support fitting 95 , and seals around the push rod 90 where it passes through the bushing 105 and contacts the trigger assembly 89 .
- a like O-ring seal 92 seals around the push rod 90 and seals against the support fitting 95 at the opposite end adjacent to the valve 100 .
- Valve 100 reciprocates in response to fore and aft movement of push rod 90 and is used to sequence the incoming air pressure that enters the valve cavity 130 through two cross pressure ports 91 from the air supply.
- the valve 100 blocks and opens passage for the incoming pressure to travel into the injector assembly.
- the valve seals against an O-ring 101 in one direction and seals against the previous O-ring 92 in the opposite direction.
- the push rod 90 is machined with an undercut 131 to permit air to travel to the valve 100 , which than can allow it to pass up into the injector 20 , or to be blocked by the valve 100 and its seal.
- the position of the valve 100 is controlled by the position it is put in by the trigger assembly 89 .
- valve 100 When the trigger assembly 89 is not activated, the valve 100 is positioned in the air blocked or closed position by a compression spring 99 that is captured by a spring retention plug 98 threaded into the support fitting 95 . When the valve 100 is in the blocked or closed position any air pressure captured in the injection on the opposite side of the valve is bled out of the return spring cavity though a pressure bleed hole 97 .
- An O-ring seal 96 is installed at the interface air passage 132 joint between the support fitting 95 and extension housing 102 attached to the injector assembly. The air passage 132 conveys pressurized air from valve 100 into extension housing 102 to drive large return piston 83 that is connected to the vacuum piston 35 by a connecting rod 82 .
- the return piston 83 has an O-ring 84 for piston sealing and a compression spring 85 located between return piston 83 and spring retention cap 94 for the return function of the return piston 83 .
- the compression spring 85 is captured in a pocket 133 in the return piston and in a pocket 134 in the spring retention cap 94 . Air captured between the retention cap 94 and the return piston 83 is bled out of the cavity through a bleed hole 97 .
- the retention cap 94 is attached to the end of extension housing 102 with retention screws 86 .
- the air pressure into the pressure side of the return piston 83 enters through a port 135 machined in the extension housing 102 and connecting with air passage 132 .
- Plug 93 closes the end of port 135 into vacuum piston cylinder 123 .
- the extension housing 102 is provided with an O-ring seal 81 for sealing pressure around connection rod 82 and preventing air bleed into vacuum piston cylinder 123 .
- drive rod 43 is a single piece
- the present embodiment includes an alternative structure where the drive rod 43 is divided into two sections, drive rod portion 43 ′ and drive rod portion 43 ′′, with an absorbing spring between them.
- the rearward portion, drive rod 43 ′ includes retention ring 59 with compression drive spring 42 surrounding the shaft between retention ring 59 and a drive cylinder 78 at the forward end of drive rod portion 43 ′.
- Separated from drive cylinder 78 is forward drive rod portion 43 ′′ which enters ampule 25 when injection occurs.
- a small compressing spring 77 is installed between the rearward end of forward drive rod portion 43 ′′ and the drive cylinder 78 .
- This compressing spring 77 ensures that the end of the drive rod portion 43 ′′ is in constant contact with the ampule plunger 65 prior to and during injection, thereby avoiding a hard impact between drive rod portion 43 ′′ and ampule plunger 65 when the injector is initiated.
- Compressing spring 77 absorbs the initial shock when release catch 44 is rotated to release position and the tooth release catch 79 disengages with the drive cylinder 78 releasing drive spring 42 .
- FIGS. 10A and 10B provide views showing the connection of the external air supply to the injector and the related manifolding of air passages in the injector.
- the functions of the foregoing pneumatic system may be achieved with an electronic solenoid, or similar electrical or electromagnetic device, powered by batteries or other electrical source.
- the solenoid would occupy the space in extension housing 102 in place of the pneumatic piston 83 , the plunger of the solenoid being attached to connecting rod 82 .
- a battery pack providing power for the solenoid may be located under the housing 21 in place of support fitting 95 , and electrically connected to the solenoid through a switch operated by the trigger assembly 89 or a switch located elsewhere on the housing 21 .
- the operational steps of such an alternative would be the same as the pneumatic embodiment described herein.
- the injector employs the mechanical compression spring and latch mechanisms to provide the driving force of the impact impulse mechanism, it is certainly within the scope of the present invention to provide the injector in a form that is totally pneumatically or electronically operated. In such modifications, the compression drive spring and mechanical cocking and latching mechanisms would be replaced by equivalent pneumatic and electrical, electronic or electromagnetic actuators to drive both the drive rod 43 and the vacuum piston 35 .
- the chamber in which the drive rod latch 48 operates to engage the retention ring 59 on the end of the drive rod 43 would be modified to form a pneumatic cylinder with retention ring 59 modified to form a pneumatically actuated piston with drive rod 43 attached.
- Appropriate porting would be provided for directing a pneumatic fluid, such as compressed air, to either side of the piston in response to actuation of an appropriate valve, thereby reciprocating the pneumatic piston and the drive rod 43 .
- means to adjust the pneumatic force may be included thereby providing adjustment of the driving force of drive rod 43 against plunger 65 for intradermal, subcutaneous or intramuscular injections.
- the driving force generated by the solenoid may be adjusted for subcutaneous, intradermal or intramuscular injections.
- ampule 25 this is a key element of the injector device of the present invention as it is the part which holds the medicament to be injected and interfaces with the injector to apply suction generated by the injector to the skin in order to draw the skin tight for proper injection.
- the ampule 25 further interfaces with the injector to provide proper functioning of the safety interlock in the injector since release of the interlock requires establishing a fill suction on the system which cannot be achieved without the ampule 25 .
- the basic disposable, pre-filled ampule of the present invention is shown in FIGS. 11, 12 and 13 and provides containment for the medicament and means for attachment to the injector and interface with the vacuum system.
- the ampule body 67 is preferably made of plastic, glass or equivalent materials or combinations thereof that are suitable for medical use, and is provided with a cylindrical or other shape bore chamber 62 for containing the medicament Dosage markers 141 are provided on the side of the ampule 25 at the chamber 62 to indicate the amount of medicament in the chamber 62 .
- the outlet orifice 66 At the forward end of the bore chamber 62 , while the rear end of the chamber 62 is closed with an internal ampule plunger seal 65 that captures the medicament inside its chamber.
- the plunger seal 65 is contacted by the drive rod 43 when the injector is actuated and is pushed forward within the chamber 62 to eject the medicament through the orifice 66 .
- the shape of the ampule 25 is significant for proper functioning of the injector system, particularly for achieving intradermal injection.
- the body 67 of the ampule 25 is structured such that the nose portion 136 is thinner than the bore chamber portion 137 , resulting in a vertical offset 138 , or step face, to the lower surface of the ampule 25 as shown in FIG. 11 and 13 .
- This offset 138 effectively creates a pocket 139 in front of the orifice 66 into which the skin surface can be readily drawn by suction from the injector applied through suction ports 63 .
- the offset 138 of the lower surface permits ampules to be formed for intradermal, intramuscular and subcutaneous injection that can be used with the same injector 20 simply by changing the thickness of the nose portion 136 of the body 67 while the position of the bore chamber 62 relative to the upper surface of the body 67 remains the same.
- an ampule with a thin nose portion 136 will have a greater offset 138 such that the effective level of the chamber 62 will be deeper and more suited to subcutaneous or intramuscular injection, whereas a thicker nosed ampule will have a lesser offset 138 and be suitable for intradermal injection.
- FIG. 24 which shows an ampule 25 with a thick nose portion 136 being used for intradermal injection
- FIG. 26 which shows an ampule 25 with a thin nose portion 138 being used for subcutaneous injection.
- the underside of the ampule immediately surrounding the lower end of the suction ports 63 is preferably formed with a depression or well 140 with the end of the suction port 63 located at the deepest point.
- This well 140 improves the effect of the suction against the skin and assists in achieving lift of the skin into the pocket 139 . It is particularly advantageous for intradermal injections.
- the well 140 is preferably circular, whereas in ampules with two or more suction ports 63 , individual wells 140 can be formed with each port 63 or a single well 140 accommodating all ports 63 in the ampule can be formed as shown in FIG. 12 .
- FIG. 12 shows a plan view of the underside of an ampule 25 with two suction ports 63 and a single well 140 encompassing both ports.
- FIG. 13 shows a longitudinal cross-section view of the ampule 25 with the chamber 62 contoured 68 on its inner surface to provide a precision throat to aid in acceleration of the medicament by reduction of the fluid drag when the ampule 25 receives an impact impulse from the spring loaded drive rod 43 of the injector 20 .
- This reduction of the fluid drag increases the acceleration of the piston 65 resulting in a faster pressure rise and injection of the medicament for the relative force of the compression drive spring 42 . Therefore, the medicament 31 is driven out of the ampule 25 with a known controlled impact impulse force.
- the position and location of the orifice 66 center line relative to the underside plane 69 of the vacuum port 63 can be varied further tailoring the ampules for interdermal, subcutaneous or intramuscular injection medicaments. This also allows injection horizontally or vertically or at any variation of angle therebetween, whether laterally or skewed, through human or animal skin to predetermined depths in the skin layer 64 , the dispersement of the medicament in injections being controlled by variation of the angle of the orifice 66 to the vacuum port level plane 69 and the centerline of the ampule.
- the ampule 25 includes locking tabs 61 on each end for engagement with and latching to the injector 20 .
- the locking tabs 61 also serve to correctly position and retain the ampule 25 on the injector 20 for accurate engagement of the suction ports 63 with the vacuum suction tubes 71 and alignment of the drive rod 43 with the chamber 62 and plunger 65 .
- the interface between the surface of the ampule and the suction tubes 71 is sealed by vacuum port seal 70 so as to ensure proper suction through ports 63 to engage recipient's skin for stretching the skin 64 between ports 63 for the medicament injection into recipient's skin 64 .
- the ampule 25 may be filled with medicament 31 from an external supply by use of an adaptor assembly 103 , shown in FIG. 14 , that holds the ampule 25 and seals it for filling the medicament through a rubber seal 104 in the adaptor that aligns with and permits filling of ampule 25 through its orifice 66 .
- the adaptor 103 comprises a housing having means to receive and hold the ampule 25 so that the orifice 66 is in registration with a passage 115 through the rubber seal 104 .
- a standard Luer connector 142 provides a means for attachment of a filling syringe.
- FIGS. 15 through 18 An alternative ampule embodiment incorporating means to permit direct filling of the bore chamber 62 with medicament is shown in FIGS. 15 through 18 .
- the ampule is provided with a filling port 143 in the upper surface of the ampule 25 that is closed by a resealable rubber stopper 106 .
- FIG. 16 shows an unfilled ampule 25 in which filling port 143 connects with bore chamber 62 through passage 115 .
- a plug 118 closes orifice 66 and protective coverings 107 and 108 maintain the sterility of the ampule surfaces and interior.
- FIG. 17 shows the operation of filling the ampule of this embodiment.
- a probe 111 on a nozzle 110 is inserted through the stopper 106 in the filling port 143 of the ampule 25 .
- the nozzle 110 includes a shoulder stop 116 that bears on the upper flat surface 114 of the ampule 25 and locates the probe 11 correctly for the medicament filling.
- Air must first be evacuated from the ampule passage 115 and the air space 113 within the ampule 25 . This is accomplished with the use of syringe 109 and its retraction handle 112 to draw the air out prior to filling the ampule 25 with the medicament.
- the probe 111 of a nozzle 110 on a syringe 109 containing medicament, or the original syringe 109 now containing medicament, is reinserted through the stopper 106 and the is used to fill the ampule 25 with a prescnbed medicament after air evacuation.
- the pressure of the medicament being injected through probe 11 and passage 115 into space 113 pushes plunger 65 rearward in bore chamber 62 .
- FIG. 18 shows a means for plugging of the ampule orifice 66 with a plug 118 when filling the medicament.
- Plug 118 contains an enlarged head 119 for ease of installation and removal with a capture pad 117 to seal against the surface of the ampule 25 and to prevent the plug 118 from being sucked into the orifice 66 .
- a protective outer doubler covering 121 serves as a means to prevent the plug 118 from being driven out of the orifice 66 during filling. All other openings in the ampule 25 are protected with coverings 107 and 108 to maintain full sterile conditions within the ampule 25 and provide for removal and disposal of the ampule orifice plug 118 when protective covering 108 is removed.
- protective coverings 107 and 108 include tabs which may be grasped for easier removal of the shields from the ampule 25 .
- FIG. 1 and FIG. 2 shows the envelope of the needle-free injector top view and side-view respectively.
- the injector assembly 20 comprises a housing 21 that holds the injector assembly components which are actuated by an external handle 30 and a release button 23 , shown in the top view.
- FIG. 2 illustrates the means for installation of the medicament filled ampule 25 into the injector 20 and provides access panel 27 , end cap 28 , and insert fairing 74 as removable units for assembly and service of the injector.
- FIG. 3 and FIG. 4 provide a cross section view of the injector assembly with the handle 30 in both a rotated up and a rotated down position and the resultant position of all of the components contained in the housing 21 respectively.
- This embodiment covers the use of a single prefilled ampule 25 and shows how it is captured in the injector assembly.
- the ampule 25 has projecting tabs 61 that engage a notched cavity in the insert fairing 74 at one end are and positioned and retained against the nose of the housing 21 at the other end with retainer clamp 22 that pivots outward away from the ampule 25 to release it and provide for replacement after the ampule 25 has been used.
- the ampule 25 includes at least one vacuum suction port 63 for interfacing with the injection recipient's skin.
- the ampule 25 installation in the injector 20 positions the ampule 25 under and against a seal 70 that provides sealing between the ampule 25 and a pair of suction tubes 71 that are utilized to convey a vacuum to the ampule vacuum ports 63 .
- the suction tubes 71 at their opposite ends interface with a machined-in manifold 72 in the housing 21 .
- the ampule retainer clamp 22 is retained in the ampule capture position with a detent projection on the retainer clamp that engages a small pocket in the housing 21 and, when the retainer clamp 22 is in the ampule retention position, the clamp 22 snaps into the pocket for firm retention. On release of the clamp 22 it is rotated around the upper detent pocket for ampule removal.
- a drive rod 43 travels in a bored hole in the housing 21 structure and is driven into a chamber opening in said ampule 25 contacting a plunger 65 therein to force under pressure the fluid out of the ampule 25 through an orifice 66 .
- the drive rod 43 is driven into the ampule 25 by a large compression drive spring 42 that applies load against a projecting ring 120 on the drive rod 43 and at the opposite end against an abutment surface 124 of the housing structure.
- the injector assembly is provided with handle 30 that stradles the assembly and pivots around a pinned pivot 24 .
- the compression spring 42 When the handle 30 is rotated up toward the housing 21 , the compression spring 42 is compressed and is retained at the preloaded compressed location by a release catch 44 that pivots around a pin 58 containing a torsion spring 53 .
- the torsion spring 53 preloads the release catch 44 down to readily latch the drive rod 43 when the projecting drive rod ring 120 passes by the tooth 79 of release catch 44 .
- the drive rod 43 To compress the compression spring 42 that encircles the drive rod 43 , the drive rod 43 also has, at its rearward end termination, retention ring 59 that is used by drive rod latch 48 to pull on the drive rod 43 and compress the compression spring 42 in response to upward rotation of the handle 30 .
- the handle 30 connects to a link 40 that has pivot points 41 and 60 at each end and connects to slide frame 45 that slides in machined grooves in the housing 21 .
- the slide frame 45 is moved horizontally in the grooves by the handle 30 pushing the link 40 that in turn moves the slide frame 45 .
- FIG. 3 and FIG. 4 illustrate the two positions of the slide frame 45 and the handle 30 .
- An upright leg on the slide 45 is attached to the drive rod latch 48 that is used to pull the drive rod 43 and compression spring 42 to the compressed loaded energy stored condition.
- the drive rod latch 48 pivots around a pivot point pin 52 that holds and engages a connecting link 47 and a torsion spring 53 that biases the drive rod latch 48 upward to the unlatched position to ensure that drive rod 43 will be released when the injector 20 is actuated.
- the drive rod latch 48 To ensure that the drive rod latch 48 will rotate downward against the torsion spring load the drive rod latch 48 is guided down to the latched lock position with a ramp 50 .
- the ramp 50 is retained in the housing structure 21 with two roll pins 51 and the ramp 50 is sloped to match the angular end termination of the drive rod latch 48 .
- the drive rod latch 48 includes a projecting hook surface on the opposite side of the latch to catch and hold the drive rod retention ring 59 for pull back.
- the drive rod retention ring 59 preferably has a concave depression in the forward face to ensure that the projecting hook of the drive rod latch 48 will stay engaged while the handle 30 is squeezed to pull the drive rod 43 back.
- the compression spring 42 drives the drive rod 43 into the ampule 25 and injects the fluid out of the orifice 66 in the ampule 25 .
- the forward side of the drive rod projecting ring is provided with a plastic or rubber washer 75 for noise deadening purposes.
- the connector link 47 that is connected to the slide frame 45 is connected at its opposite end to a pin 54 that engages an extension 46 on a piston 35 that provides a vacuum for the ampule vacuum ports 63 .
- the connecting link 47 moves the piston in and out in its cylinder 123 .
- the piston 35 includes an O-ring seal 34 .
- the vacuum created is transmitted through suction passages 73 in the structural manifold 72 to the suction tubes 71 and, in turn, to the vacuum ports 63 in the ampule 25 as shown in FIG. 7 .
- the vacuum created by the movement of the piston 35 retracts an interlock piston rod 36 that provides a means for locking and unlocking a release arm 55 .
- Two vacuum port openings in the manifold 72 cycle the interlock piston rod 36 back and forth when interlock is required.
- the interlock piston 126 is provided with an O-ring seal 37 and a retainer ring 39 controls the length of its movement stroke and captures it in its cylinder 127 .
- the interlock piston rod 36 extends into the release arm 55 for locking and retracts out of the release arm 55 for unlocking.
- the release arm 55 pivots about a pivot pin 54 that includes a torsion spring 33 that positions the arm 55 for engagement with the piston rod 36 .
- the release arm 55 rests against the bottom surface of a release button 23 that is held in the housing 21 with a snap ring 32 .
- the release button 23 is pressed down by the operator it presses down on the release arm 55 and rotates it, which in turn drives the release catch 44 upward to disengage from the drive rod 43 , which is then driven into the ampule 25 by the compression spring 42 and injects the medicament into the skin tissue of the recipient.
- the ampule 25 is illustrated in FIG. 11 side view and FIG. 12 shows a top view of the ampule 25 .
- the ampule 25 is manufactured from one or more of a variety of plastics, or glass, or equivalent medical grade materials.
- the ampule 25 has at least one vacuum port 63 for use in positioning, stretching and holding the recipient's skin 64 .
- the ampule 25 further has at least two locking tabs 61 and an internal cylinder bore chamber 62 for containment of the preloaded medicament. Dosage markers are provided on the outer surface of the ampule 25 adjacent to the bore chamber 62 . Contained within the bore chamber 62 is an ampule plunger 65 , shown in FIG.
- the bore chamber 62 is preferably contour shaped 68 to enhance the injection process.
- the ampule 25 and the injector 20 are unique in that the ampule 25 uses a vacuum produced by the injector 20 to stretch and properly hold the recipient's skin for the medicament to be injected into the skin. Stretching the skin increases permeability which reduces the amount of energy required to inject fluid into a tissue. Injecting the fluid horizontally to the skin allows controlled positioning of the tissue for ID, Sub-Q and IM injections.
- the bore 62 and orifice 66 are designed to accelerate the fluid with minimal drag by a refined throat contour 68 .
- the size and length of the ampule's bore are also optimized to minimize turbulent flow and thus drag and this will reduce pain and energy required to penetrate the epidermal tissue. This process of injection of medicament fluid into the tissue spreads the particles of the medicament over a larger area than using a needle syringe and, in turn, decreases the local pressure in the tissue and eliminates leakage of the fluid from the injection opening in the tissue, which in turn reduces possibility of spreading infections.
- FIG. 19 shows the side view of the injector 20 of the present invention adapted to receive and fitted with a multiple ampule assembly 200 .
- the function, operation and internal components of the injector 20 are the same as those presented previously in the said single ampule embodiments with the exception of the ampule, its attachment to and retention on the injector 20 and the technique of ampule replacement.
- FIG. 12 illustrates a cross section view of the multiple ampule injector assembly with manual embodiment single ampule injector components.
- the air powered embodiment may be similarly modified to receive the multiple ampule assembly 200 . Since the mechanical operation of the manual and air powered injectors 20 is the same as described previously herein, the description thereof will not be repeated except as necessary to for a clear understanding of the multiple ampule embodiment.
- the multiple ampule injector housing 201 comprises a rotatable multiple unit cartridge 205 that contains multiple medicament filled ampules 25 molded into a plastic or equivalent material cylinder 222 as shown in FIG. 21 and FIG. 22 .
- the cylinder 222 is rotatable around a center shaft 206 as shown in FIG. 20 and FIG. 21 .
- the cylinder 222 is manually rotated by a rotation knob 208 rotatably attached to the end of the shaft 206 .
- the cartridge 205 containing the ampules 25 is keyed to the shaft 206 by a sleeve 209 to provide a means for rotation and positioning of the ampules 25 for fluid injection.
- a position detent 207 is installed in the injector housing 21 and positions and detents into a series of pockets 204 in the rim of the cartridge 205 .
- a similar detent 214 in the injector housing 21 engages an annular groove 213 adjacent to the end of the shaft 206 to capture and hold the multiple unit assembly 200 on to the end of the injector 20 .
- the detents 207 and 214 are ball 215 and spring 216 mechanisms as shown, but other detent mechanisms providing similar function may be used.
- the rotation knob 208 is keyed and retained on the sleeve 209 with a knob capture pin 223 so that when the knob is rotated it rotates the cartridge 205 in the housing 201 around the shaft 206 but does not rotate the shaft 206 itself.
- the sleeve 209 attached to the knob 208 keys in the cartridge 205 and turns it to the various ampule positions whereupon the position detent 207 engages the pocket 204 for that position and holds the ampule 25 in registration with the drive rod 43 .
- each ampule 25 contains a set of vacuum ports 203 , preferably two, but at least one, and an internal cylinder bore chamber 62 for containment of the preloaded medicament.
- each ampule 25 of the multiple unit 200 is provided with dosage markers on its outer surface.
- each ampule 25 contains within its bore chamber 62 an ampule plunger 212 that captures and contains the said medicament.
- the bore chambers 62 duplicate the contour shape, size, length and configuration as presented in the prior single ampule embodiment and, therefore, the injection procedure, method of injection and results of the injection are identical.
- the multiple unit assembly 200 contains a similar suction tube 210 and a seal 211 for interface with each ampule that is positioned for fluid injection.
- a stepped surface on the cartridge's sleeve 209 bears down on the suction tube 210 to enhance the seal 211 interface between the suction tube 210 and the ampule 25 .
- the suction tube 210 connects to the injector's manifold system in a manner identical to the previous embodiments.
- each individual ampule of the multiple unit may be protected by a removable tab 220 prior to use.
- a multiple unit ampule assembly 200 having the desired medicament preloaded in the ampules 25 will be selected and installed on the injector 21 by insertion of the end of shaft 206 into a blind shaft receiving hole 218 bored in the end of injector housing 21 until detent 214 engages the groove 213 in the end of shaft 206 , thereby holding multiple unit assembly 200 in place.
- the engagement of detent 214 and groove 213 is of sufficient strength to hold multiple unit assembly 200 in place against inadvertent displacement, but not so strong that the multiple unit assembly 200 cannot be readily removed for replacement another assembly 200 .
- knob 208 is rotated to bring an ampule into position and the injector is operated as previously described.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
A needle free hypodermic injector comprising a hand manipulatable elongate housing, an impact impulse injection mechanism within the housing, a suction generating means within the housing and cooperable with the impact impulse injection mechanism, a safety interlock mechanism, at least one medicament containing ampule cooperable with the impact impulse injection mechanism and the suction generating means and having a jet orifice through which medicament is injectable through a skin surface in response to an impulse placed on the medicament by the impact impulse injection mechanism, and means to receive and hold the ampule on the injector in registration with the impact impulse injection mechanism and in communication with the suction generating means; whereby the injector is adapted to expel the medicament from the ampule in a jet stream of sufficient velocity to penetrate skin tissue held against the orifice by the suction generating means and to deposit the medicament intradermally, subcutaneously or intramuscularly based on the position and angle of the jet orifice.
Description
- This invention relates to a needle free, impact impulse injector device and disposable, single use, fillable or pre-filled, ampules therefor that are capable of delivering intradermal, (ID), subcutaneous (SUB-Q) and intramuscular (IM) injections in human or animal tissue by means of a thin high pressure liquid jet stream of sufficient velocity to penetrate the tissue of the recipient. The injector deposits medicament intradermally, or subcutaneously, or intramuscularly, utilizing the single use, disposable, medicament ampules that are designed to provide interfaces to the activation device, allowing easy installation by hand or mechanically from a multiple ampule dispensing apparatus, and providing exact positioning and sealing to the activation device structure. The ampules further contain features that induce a vacuum to stretch the skin, keeping the skin precisely aligned with the jet orifice for the short duration of the injection. The ampule's orifice has different offset variations for ID, SUB-Q or IM injections. Ampules and injectors may also be adjusted for variations in medicament viscosity as required by various classes of medicaments including providing multiple orifices in the ampule for injection of larger doses or wider patterns. The injector device is manually, pneumatically and/or electrically or electromagnetically activated and provides interface features for mounting the ampules, and features rendering it possible for the impulse force to inject the medicament at any angle from horizontal to vertical relative to the skin surface as well as at skew angles, as the activation process is performed. In addition, the activation device provides safety interlock features which prevent the impulse force from being inadvertently activated, except when the ampule is properly interfaced with the skin surface. The injector provides the operator with a comfortable, light weight device that allows the operator to quickly and easily load an ampule, properly position the ampule on the skin surface, activate the impulse force, inject the medicament and reset the activation device.
- In this invention, a needle-free ampule is provided which discharges a pre-measured quantity of fluid medicament in a thin jet at a sufficient velocity to penetrate the tissue of both humans and animals to be treated or vaccinated at any angle from horizontal to vertical. This invention utilizes a single-use, disposable medicament ampule having the capability to apply a vacuum to stretch and properly hold the skin prior to injecting a medicament into the tissue, and a manually, pneumatically, electrically or electromagnetically operated activation injector device. The ampule and the injector are truly unique designs constructed with materials presently being used in the medical industry and designed to minimize effort, be easy to handle and operate. The size and shape selected also minimize weight. The age, size of hands, hand strength, skin type and thickness, as well as visibility of operations, were very important considerations.
- Present state of the art attempts to inject medications intradermally have met with only limited success due to the inherent difficulty associated with accurate positioning of the skin relative to the injector jet opening and the lack of precise control of the jet pressure vs. skin penetration when the injection is performed normal to the skin surface. In addition, present systems lack precise control and repeatability of the injection jet velocity due to mechanical equipment tolerance variations within the pressure/force generators utilized. Some present devices present safety concerns due to the lack of safety interlocks to prevent the device from being activated when not in proper contact with the skin, and catastrophic failures have been observed in the injector bodies in part caused by the lack of pressure control inherent in the device designs.
- Of particular interest is the ability to deliver medicament to Langerhans cells within the skin. Langerhans cells are dendritic cells generally located in the upper spinosum layer of the skin. These cells are known to participate in cutaneous immune responses and migrate from the skin to the lymph nodes. They possess surface receptors common to macrophages and function as antigen presenting cells to T and B lymphocytes. The Langerhans cells serve to fix and process cutaneous antigens and, as such, are the first immune cells to arrive at sites of inflammation. For this reason, Langerhans cells are of particular interest in immune system studies with respect to enhancing vaccine development and creating treatments for auto-immune diseases and anti-rejection therapies.
- Needleless injectors have been used as an alternative to hypodermic needle type injectors for delivering drugs, vaccines, local anaesthetics and other fluids into the human or animal tissue. The medicament is discharged at high velocity so as to first penetrate the epidermis and thereafter be deposited in the tissues of the subject. An alternative method is to press the discharge nozzle onto the skin and force the fluid at very high pressure through the epidermis. Such prior art devices result in substandard and painful injections because of this blasting action and the inability to address the variables of flow control once the skin is penetrated. They are also deficient with respect to being able to provide the force necessary to penetrate the stratum corneum while restricting medicament delivery to the intradermal area generally and, specifically, the upper layers of the skin.
- Prior art devices generally employ spring loaded piston pumps to withdraw fluid from a reservoir. At the end of the piston retracting stroke, the piston is disengaged from the retracting mechanism and reverses direction to pressurize the fluid for ejection from the delivery nozzle. In some devices the fluid is contained in an adjacent container or vessel within the device and the fluid is fed into the nozzle under pressure and discharged under pressure through the delivery nozzle. In other prior art devices the piston is driven on the discharge stroke by gas or an electric motor instead of a spring. In most of these devices the discharge orifice must be placed firmly on the skin to make direct contact of the nozzle with the epidermis. To achieve suitable contact, the orifice is pressed firmly into the epidermis by the operator at an angle that is normal to the skin surface, usually perpendicular to the plane of the skin, so as to stretch the epidermis at the point of contact and thereby increase the ability of the injection to penetrate the stretched tissue at the point of contact. However, the pressing of the orifice into the epidermis is a variable that is dependent on the device's operator and the ability of the recipients to tolerate the device being pressed against their anatomy.
- Typically, the use of existing devices results in loss of medicament at the nozzle entry point, poor injections on account of the recipient's movements or the operator's inexperience and receipt of the injection at an angle that either does not penetrate or penetrates too much for placement and dispersal of the medicament at the correct depth and layer of tissue. In addition, premature operations are common, as well as relative movement between the epidermis and orifice which can cause tearing of the skin during injection, resulting in pain and poor transfer of the medicament to the recipient. In other instances, the epidermis will deform away from the orifice and the injection fluid will leak away from the point of entry. At other times, the devices attempt to stretch the epidermis by deforming over the discharge orifice. In all of these conditions, the success of the injection procedure depends and rests on the ability of the operator to consistently perform, using the device to get an acceptable discharge and penetration of the epidermis.
- Various methods have been proposed to overcome these problems such as powered injectors, sensing and control devices to enhance their performance, including compressed gas cylinder and electrical injectors, which are often heavy and unwieldy and encumbered with variations in gas supply, pressure, leakage.
- The need for medicament supply and personnel skill have produced problems for using these devices, for example, precisely measuring and controlling of the quantity of medicament administered and ensuring that the injector delivers the correct amount of medicament into the proper tissue. The following patents have attempted to address these known problems, with varying degrees of success, and proposed some methods as follows:
- U.S. Pat. No. 3,859,996, Mizzy, discloses a controlled leak method to ensure that the injector orifice is placed correctly at the required pressure on the subject's skin and at the correct attitude to the skin. When placement conditions are met, controlled leak is sealed off by contact pressure on the subject's skin and the pressure within the injector control circuit rises until a pressure sensitive pilot valve opens to admit high pressure gas to drive the piston and inject the medicament. This use of valving and pressure gas renders the device complex to manufacture and use and does not apply to the present invention.
- WO
Patent 82/02835, Cohen and Ep-A-347190, Finger, disclose a method to improve the seal between the orifice and the skin and prevent relative movement between each. This method is to employ a vacuum device to suck the epidermis directly and firmly onto the discharge orifice. The discharge orifice is positioned normal to the skin surface in order to suck the epidermis into the orifice. This method for injection of the medicament into the skin and the injector mechanism are different and do not apply to the present invention because of its unique ampule design. - U.S. Pat. No. 3,859,996, Mizzy, further discloses a pressure sensitive sleeve on the injector which is placed on the subject and whereby operation of the injector is prevented from operating until the correct contact pressure between orifice and the skin is achieved. The basic aim is to stretch the epidermis over the discharge orifice and apply the pressurized medicament at a rate which is higher than the rate at which the epidermis will deform away from the orifice. This method of stretching the skin on to the orifice, together with the arrangements of the mechanism are totally different from the present invention and, consequently, do not apply.
- U.S. Pat. No. 5,480,381, T. Weston, discloses a means of pressuring the medicament at a sufficiently high rate to pierce the epidermis before it has time to deform away from the orifice. In addition, the device directly senses that the pressure of the discharge orifice on the subject's epidermis is at a predetermined value to permit operation of the injector. The device is based on a cam and cam follower mechanism for mechanical sequencing, and contains a chamber provided with a liquid outlet for expelling the liquid, and an impact member, to dispell the liquid. The sequencing and cam operation are driven by an electric motor gear-box, and along with the cam action sequencing and adjustable pressure sensing do not apply to the present invention.
- U.S. Pat. No. 5,891,086, T. Weston, describes a needleless injector that contains a chamber that is pre-filled with a pressurized gas which exerts a constant force on an impact member in order to strike components of a cartridge and expell a dose of medicament. This device contains an adjustment knob which sets the dose and the impact gap, and uses direct contact pressure sensing to initiate the injection. This use of contact pressure sensing, the need for constant adjustment and the use of pressurized gas to implement the injection process do not apply to the present invention.
- The subject of the present invention represents an innovative approach to hypodermic needle-free injections, either Intradermal (ID), Subcutaneous (SUB-Q) or Intramuscular (IM), providing a process and a mechanization which contains disposable filled or prefilled medicament ampules and a manuallyor automatically operated activation device. There are many advantages covered by this invention. Above all, the injection uses horizontal impact impulse jet pressure, and thus it spreads the particles over a larger area than using a needle syringe, decreases the local pressure in the tissue, and eliminates leakage of the fluid from the opening in the tissue thereby reducing the possibility of spreading infections. The apparatus is capable of injection at any angle between horizontal and vertical in addition to laterally relative to the center line of the ampule, depending on the specific conditions of the medicament, injection site, etc. A unique feature of this invention is that the medicament is driven out of the ampule that holds it with a known and controlled impact impulse force.
- A further innovation of the present invention is the process of the stretching of the skin, which increases permeability thus reducing the amount of energy required to inject fluid into a tissue, in conjunction with the injecting of the fluid horizontally to vertically and/or laterally into the skin which allows controlled positioning of the tissue for intradermal, subcutaneous or intramuscular injections. Also significant is the introduction of a safety feature built into the injector that will not allow operation until the skin is properly positioned.
- The ampule interfaces with the injector allowing installation by hand or mechanical means, and has features for the application a vacuum produced by the operation of the injector that stretches and properly holds the skin, precisely aligned with the jet orifice during the short duration of the injection. The activation device provides the interface for mounting the ampule and for delivering the impact impulse force required to inject the medicament as the activation process is performed. Each ampule body includes a see through window with external gradient markers to indicate the quantity of medicament the ampule contains.
- In a second embodiment of this invention, the injector operates in like manner as the primary embodiment, with the exception that certain functions and sequence operating components utilize external air pressure for activation. The handle has been replaced with a finger operated trigger, and return functions are all air driven. Alternatively, the pneumatic operation can be achieved using an electronic solenoid with power provided by a battery pack that may be part of or separate from the injector. The ampule configuration in both embodiments is identical and its attachment to the injector and filling procedure are the same. Inasmuch as each injector embodiment utilizes the same ampule, then each provides a means for administering either Intradermal (ID), Subcutaneous (SUB-Q) or Intramuscular (IM) injections.
- A still further embodiment of the present invention provides an injector that is adapted to receive a multiple ampule assembly and a multiple ampule assembly therefor. The components and operation of the injector are substantially identical to those of the other embodiments except that the front end of the injector is modified to receive a rotatable, multiple ampule assembly, which assembly has a plurality of ampules arranged in a cylindrical cartridge. The cartridge is rotatable on the forward end of the injector so as to bring each ampule thereof into registration with the suction and injection means of the injector.
- Present state of the art attempts to inject medications intradermally have met with only limited success due to the inherent difficulty associated with accurate positioning of the skin relative to the injector jet opening and the lack of precise control of the jet pressure versus skin penetration when the injection is performed normal to the skin surface. In addition, present systems lack precise control and repeatability of the injection jet velocity due to mechanical equipment tolerance variations within the pressure/force generators utilized. Some present devices indicate safety concerns due to the lack of safety interlocks to prevent the device from being accidentally activated when not in proper contact with the skin, and observed catastrophic failures in the injector bodies in part caused by the lack of precise pressure control inherent in the device designs.
- The present invention overcomes these deficiencies by the combination of the injector device and the ampule used therewith. The ampule is a key element of the system as it is the part which holds the medicament to be injected and interfaces with both the injector and the patient's skin surface to apply the suction generated by the injector in order to draw the skin tight for proper injection. The ampule further interfaces with the injector to provide proper functioning of the safety interlock since release of the interlock requires establishing a full suction on the system which cannot be achieved without the ampule. With the ampule and the injector combination of the present invention it is now possible to achieve needle-less injection of medicament intradermally, subcutaneously and intramuscularly at any angle relative to the skin surface. Furthermore, the ampule and injector combination of the present invention are capable of achieving the shallow intradermal injection necessary to accurately and reliably deliver medicament to the Langerhans cells in the upper spinosum layer of the skin.
- Thus, the present invention provides a needle free hypodermic injector comprising a hand manipulatable elongate housing, an impact impulse injection mechanism within the housing, a suction generating means within the housing and cooperable with the impact impulse injection mechanism, a safety interlock mechanism, at least one medicament containing ampule cooperable with the impact impulse injection mechanism and the suction generating means and having a jet orifice through which medicament is injectable through a skin surface in response to an impulse placed on the medicament by the impact impulse injection mechanism, and means to receive and hold the ampule on the injector in registration with the impact impulse injection mechanism and in communication with the suction generating means; whereby the injector is adapted to expel the medicament from the ampule in a jet stream of sufficient velocity to penetrate skin tissue held against the orifice by the suction generating means and to deposit the medicament intradermally, subcutaneously or intramuscularly based on the position and angle of the jet orifice.
- The present invention further provides an ampule for a needle free hypodermic injector, wherein the ampule comprises an elongated body having a forward end, a rearward end, a substantially planar upper surface and a lower surface having a downward offset between the forward end and the rearward end, this offset providing a forward facing step face, a horizontally disposed bore within the body extending from the rearward end of the body to a point substantially adjacent to the step face, the bore being open at the rearward end and having a sealing plunger disposed therein to be driven by the impact impulse mechanism, the bore further having a jet orifice extending through the step face, whereby the bore is capable of holding a quantity of medicament injectable through a skin surface held against the orifice in response to the plunger being driven forward in the bore by the impact impulse injection mechanism.
- The present invention still further provides a needle free hypodermic injector wherein the ampule further comprises at least one suction port extending vertically through the body from the upper surface to the lower surface at a point forward of the step face, the suction port being in fluid communication with the suction generating means whereby a suction generated by the suction generating means is applicable to the skin surface through the port to draw the skin surface upward against the lower surface of the ampule and the jet orifice prior to injection thereby stretching the skin to improve its porosity to the jet of medicament and, depending on the angle and placement of the orifice, to direct the jet of medicament intradermally, subcutaneously or intramuscularly.
- The present invention still further provides a needle free hypodermic injector comprising an injector assembly and at least one medicament containing ampule removably attachable to the injector assembly, the injector assembly comprising an elongated hand manipulatable housing, the housing comprising a main body portion containing a mechanical impact impulse means comprising a drive rod linearly reciprocatable within the housing between a cocked position and an injection position, a compressible drive spring linearly concentric about a rear portion of the drive rod, the spring being confined between a stationary abutment within the housing and a projection substantially midway along the drive rod whereby rearward displacement of the drive rod compresses the spring, a latch mechanism cooperating with the projection to releasably hold the drive rod in a cocked position wherein the spring is compressed, a release means to release the latch mechanism when injection is desired, and a cocking means cooperating with the drive rod and operable to draw the drive rod in a rearward direction to the cocked position thereby compressing the spring and engaging the latch mechanism. The injector further comprises a forward nose portion adapted to removably receive at least one ampule and having detent means to releasably secure the ampule to the injector assembly when the impact impulse mechanism is in the cocked position, the at least one ampule comprising a body having a forward end and a rearward end, a substantially planar upper surface and a stepped lower surface having a forward facing step face therein, the body having formed therein behind the step face a horizontally disposed substantially cylindrical medicament chamber open at the rearward end and narrowing to a jet orifice in the step face, the chamber being sized and positioned to receive a forward end of the drive rod when the ampule is secured to the injector assembly and the latch mechanism is released, the chamber further containing a sealing plunger providing a means to retain medicament in the chamber, the plunger adapted to be engaged by the drive rod upon release of the latch mechanism, whereby the drive rod drives the plunger forward within the horizontally disposed chamber forcing the medicament under pressure through the jet orifice for injection into a skin surface held against the ampule.
- The needle free hypodermic injector of the present invention further comprises at least one suction port vertically disposed through the ampule body forward of the jet orifice, a suction generating means disposed in the main body portion of the housing and suction conduits within the housing and the nose portion providing fluid communication between the suction generating means and the at least one suction port whereby suction generated by the suction generating means is conveyed to the at least one suction port of the ampule, the suction serving to draw the skin surface against the ampule and the orifice prior to injection. To improve the suction of the skin surface against the ampule and, preferably in the case of intradermal injection, to lift the skin surface slightly higher than the level of the jet orifice thereby providing an injection path to the spinosum layer of the skin, it is preferred that the lower surface of the ampule immediately surrounding the suction port be concave thereby forming a slight depression into which the skin is drawn by the suction.
- Although the injector does not touch the skin tissue around the injection, it can be submerged in alcohol for sterilization, if desired, since all materials are presently being used in the medical industry, and are compatible with all current sterilization methods.
-
FIG. 1 is a top view of the needle-free injector of the present invention. -
FIG. 2 is a side view of the needle-free injector in a manual configuration. -
FIG. 3 is a longitudinal cross section of the needle-free injector ofFIG. 2 prior to injection. -
FIG. 4 is a cross section of the needle-free injector ofFIG. 2 after injection. -
FIG. 5 is a view of the end cap of the needle-free injector ofFIG. 2 . -
FIG. 6 is a vertical cross section through the injector ofFIG. 2 at the vacuum piston. -
FIG. 7 is a partial longitudinal cross section of the injector ofFIG. 2 through the suction manifold. -
FIG. 8 is a longitudinal cross section of an alternative embodiment of the injector configured for operation by air pressure prior to injection. -
FIG. 9 is a longitudinal cross section of the alternative embodiment of the injector configured for operation by air pressure after injection. -
FIG. 10A is a side view of the return piston housing of the alternative embodiment of the injector ofFIG. 8 . -
FIG. 10B is an end view of the return piston housing of the alternative embodiment of the injector ofFIG. 8 . -
FIG. 11 is a side view of an ampule according to the present invention. -
FIG. 12 is a top view of an ampule according to the present invention. -
FIG. 13 is a longitudinal cross section through the ampule ofFIG. 11 . -
FIG. 14 is a view of an ampule in an adaptor for filing. -
FIG. 15 is a top view of an alternative embodiment of an ampule according to the present invention having a stopper for filing via a hypodermic syringe. -
FIG. 16 is a longitudinal cross section of the ampule ofFIG. 15 with protective coverings in place. -
FIG. 17 is a longitudinal cross section of the ampule ofFIG. 15 being filled. -
FIG. 18 is a longitudinal cross section of the ampule ofFIG. 15 filled with medicament and sealed for use. -
FIG. 19 is a side view of a multiple ampule unit injector. -
FIG. 20 is a longitudinal cross section of the multiple ampule unit injector ofFIG. 19 . -
FIG. 21 is a detailed cross section of the forward end of the multiple ampule unit injector ofFIG. 19 . -
FIG. 22 is a vertical cross section of the multiple ampule unit injector ofFIG. 19 through the vacuum ports of the ampule assembly. -
FIG. 23 is a view of the ampule assembly showing adjacent ampules. -
FIG. 24 is a view showing an intradermal injection ampule in use. -
FIG. 25 is a close-up view of the intradermal injection. -
FIG. 26 is a view showing a subcutaneous injection ampule in use. -
FIG. 27 is a close-up view of the subcutaneous injection. -
- 20—Injector Assembly (complete)
- 21—Housing
- 22—Retainer Clamp
- 23—Release Button
- 24—Pivot (Handle)
- 25—Ampule
- 26—Detent
- 27—Access Panel
- 28—End Cap
- 29—Hand Grips
- 30—Handle
- 31—Medicament
- 32—Snap Ring
- 33—Torsion Spring
- 34—Seal (Large Piston)
- 35—Vacuum Piston
- 36—Interlock Piston Rod
- 37—O-Ring
- 38—Suction Port A
- 39—Retainer Ring (Small Piston)
- 40—Extension Link
- 41—Pivot (Link)
- 42—Drive Spring
- 43—Drive Rod
- 44—Release Catch
- 45—Slide Frame
- 46—Extension (Piston)
- 47—Connector Link
- 48—Drive Rod Latch
- 49—External Air Source Fitting
- 50—Ramp
- 51—Roll Pins
- 52—Pivot (Rod Latch)
- 53—Torsion Spring (Rod Latch)
- 54—Pin
- 55—Release Arm
- 56—Shaft
- 57—Pivot (Release)
- 58—Pin (Latch)
- 59—Retention Ring
- 60—Pivot (Slide)
- 61—Locking Tabs
- 62—Cylinder Bore (with dosage markers)
- 63—Suction Ports
- 64—Skin
- 65—Ampule Plunger
- 66—Outlet Orifice
- 67—Ampule Body
- 68—Contour
- 69—Vacuum Port Plane
- 70—Vacuum Port Seal
- 71—Suction Tube
- 72—Suction Manifold
- 73—Suction Passage
- 74—Insert Fairing
- 75—Cushion Washer
- 76—Screw
- 77—Compression Spring
- 78—Drive Cylinder
- 79—Tooth Release Catch
- 80—Interlock Hole
- 81—O-Ring
- 82—Connecting Rod
- 83—Return Piston
- 84—O-Ring
- 85—Compression Spring
- 86—Retention Screws
- 87—Actuation Frame
- 88—Pin
- 89—Trigger Assembly
- 90—Push Rod
- 91—Pressure Ports
- 92—O-Ring
- 93—Plug
- 94—Spring Retention Cap
- 95—Support Fitting
- 96—O-Ring
- 97—Pressure Bleed
- 98—Spring Retention Plug
- 99—Compression Spring
- 100—Valve
- 101—O-Ring
- 102—Extension Housing
- 103—Luer Adaptor
- 104—Rubber Seal
- 105—Bushing
- 106—Stopper
- 107—Pull-off Protection Shield (upper)
- 108—Pull-off Protection Shield (lower)
- 109—Syringe
- 110—Nozzle
- 111—Probe
- 112—Retraction Handle
- 113—Vacuum Space
- 114—Flat Surface
- 115—Passage
- 116—Shoulder Stop
- 117—CapturePad
- 118—Ampule Orifice Plug
- 119—Enlarged Head
- 120—Projecting Ring
- 121—Protective Outer Doubler
- 122—Slide Frame Groove
- 123—Cylinder
- 124—Annular Abutment Surface
- 125—Channel
- 126—Small Piston
- 127—Small Cylinder
- 128—Drive Spring Chamber
- 129—Vacuum Ports
- 130—Valve Cavity
- 131—Undercut
- 132—AirPassage
- 133—Return Piston Pocket
- 134—Retention Cap Pocket
- 135—Port
- 136—Ampule Nose Portion
- 137—Ampule Bore Chamber Portion
- 138—Offset
- 139—Pocket
- 140—Depression (Well)
- 141—Dosage Markers
- 142—Luer Connection
- 143—Filling Port
- 200—Multiple Ampule Assembly
- 201—Housing
- 202—Multiple Unit Cylinder
- 203—Vacuum Ports
- 204—Detent Pockets
- 205—Multiple Unit Cartridge
- 206—Shaft
- 207—Position Detent
- 208—Rotation Knob
- 209—Sleeve
- 210—Multiple Unit Suction Tube
- 211—SuctionTubeSeal
- 212—Multiple Unit Ampule Plunger
- 213—Annular Groove
- 214—Detent
- 215—Ball
- 216—Spring
- 217—Detent
- 218—Shaft Receiving Hole
- 219—Electronic Identification Code
- 220—Removable Tab
- 221—Window
- 222—Sequential Number
- 223—Capture Pin
- This invention relates to a device and method for a needle-less jet injection of a medicament into the skin of a human or animal from a disposable tillable or pre-filled ampule that uses a vacuum to stretch the recipient's skin in order to increase its permeability for injection and which, in turn, reduces the amount of energy required to inject the medicament into the skin tissue. The vacuum further positions the skin correctly for injection of the medicament.
- The method uses the device to inject a premeasured dose of medicament by means of a high pressure jet stream of sufficient velocity to penetrate human or animal epidermis, depositing the medicament intradermally, or subcutaneously, or intramuscularly, depending on the offset and angle of the disposable ampule's orifice to the epidermis and the impact impulse force. Another novelty of the process consists in injecting the medicament horizontally, or any other desired angle, into the skin from a single use ampule, spreading the particles over a larger area than when using a needle syringe.
- The method provides decreased local pressure in the skin tissue at the point of injection, thus reducing local pain, minimizing tissue damage, eliminating leakage of fluid at the injection opening, and reducing the possibility of spreading infections, while providing a safety device to prevent inadvertent triggering of the injector.
- The
injector assembly 20 shown inFIG. 1 comprises a moldedhousing 21 containing the injector mechanism that is activated by arelease button 23. Activation of theinjector 20 disperses themedicament 31 contained inampule 25 shown inFIG. 2 . Theampule 25 is retained on theinjector 21 by aretainer clamp 22 attached to the forward end of theinjector 20 and by an insert fairing 74 on the underside of theinjector 20 at the opposite end of theampule 25. The principal embodiment of theinjector 20 is manually operated and is cocked for release of the medicament by rotation of ahandle 30, around ashaft 56. Thehandle 30 is provided with shaped hand grips 29 for ease of operation. Thehandle 30 rotates athandle pivot 24. - The
injector housing 21 is provided with anaccess panel 27 and anend cap 28 for ease of assembly and service of the mechanism within thehousing 21.FIG. 3 shows a cross section view of theinjector 20 prior to activation of the mechanism for injection. The mechanism within thehousing 21 comprises apiston 35 adapted to create a vacuum for stretching the recipient's skin at the injection site immediately prior to injection and a release mechanism to pressure drive the medicament into the skin tissue. The mechanism within thehousing 21 of theinjector 20 also comprises acompression drive spring 42 which provides the force that drives one end of adrive rod 43 into theampule 25 that contains the medicament. Thedrive rod 43 has aretention ring 59 at the opposite end which cooperates with a means for locking thedrive rod 43 with thecompression drive spring 42 compressed. A projecting ring 120 substantially midway alongdrive rod 43 provides a surface on thedrive rod 43 for thecompression spring 42 to push against. The opposite end of thecompression drive spring 42 abuts against anannular surface 123 at the end ofdrive spring chamber 128 withinhousing 21. To eject themedicament 31 from theampule 25, the mechanism of theinjector 20 is cocked by rotation of thehandle 30 to the position ofFIG. 4 , which pullsslide frame 45, viaextension link 40, forward so thatdrive rod latch 48 snaresretention ring 59 on the end of drivespring drive rod 43. As theslide frame 45 is pulled forward by thelink 40 attached to thehandle 30, the upper surface oflatch 48 slides alongspring ramp 50 and is rotated downward to engage the forward surface ofretention ring 59. Thedrive rod latch 48 is preloaded to a release position by atorsion spring 53 at the pivot point oflatch 48 andside frame 45. Contact oflatch 48 withspring ramp 50 pushes latch 48 downward against the torsion spring load to the locking position that captures the driverod retention ring 59.Spring ramp 50 is preferably retained in thehousing 21 by twopins 51. Thedrive rod latch 48 is supported by theslide frame 45 and pivots around a pin joint 52 in the upright supports of theslide frame 45 and is retained in the slide frame with ahorizontal pin 58 that also retains aconnector link 47. Theslide frame 45 has a horizontal lower leg that slides in and is guided by a machined-ingroove 122 in thehousing 21. The horizontal lower leg ofside frame 45 is provided with an endtermination pivot point 60 for pivoting attachment ofextension link 40. The rotation of thehandle 30 back to the starting position shown inFIG. 3 pushes thedrive rod 45 rearward and compresses thespring 42 betweenannular surface 123 and projecting ring 120. When handle 30 is fully rotated back to the starting position,spring 42 is fully compressed and projecting ring 120 is engaged bytooth release catch 79 which depends from the underside ofrelease catch 44 and holdsspring 42 and driverod 43 in a compressed position ready for release to drive themedicament 31 out of theampule 25 with thedrive rod 43. To achieve this movement of theslide frame 45 with thelink 40 that is attached to bothslide frame 45 and handle 30, thelink 40 rotates aroundpivot 41 on the handle and pivot 60 on the slide frame. - The
handle 30 itself is attached to theinjector assembly housing 21 and rotates around thepivot 24. The injector handle 30 attached to the outside of thehousing 21 comprises two contoured legs that straddle thehousing 21 with and each leg being attached to thepivot point 24 on either side of the housing structure bycapture pin 58. The free end of injector handle 31 is formed or molded to provide finger orhand grip 29. Thehandle 30 is of extended length in order to provide sufficient leverage for compressing the driverod compression spring 42.Extension link 40 can rotate around itshandle attachment point 41 permitting theextension link 40 to rotate when thehandle 30 is also rotated. A similar pivot connection to theslide frame 45 at pin joint 60 permits extension link 40 to pivot relative to slideframe 45 so that when thehandle 30 is rotated down or up theextension link 40 pushes or pulls on theslide frame 45. - In addition to pulling
drive rod 43 againstcompression spring 42, theslide frame 45 has a second function. To ensure good contact of theampule 25 with the skin of the recipient, during the medicament injection, theinjector 20 creates a vacuum at this contact point of theampule 25 and the recipient's skin. To achieve this vacuum, theslide frame 45 has attached to it asecond connector link 47 extending rearward fromlatch 48 to engagevacuum piston 35 in the rear ofhousing 21. Theslide frame 45 movement in the rearward direction compresses thecompression spring 42 and pulls thedrive rod 43 to the cocked position. Simultaneously,connector link 47 which is attached to the upright supports of theslide frame 45 at one end and pin joint 51 bycapture pin 58 at the opposite end is attached topiston extension 46 by rodlatch pivot pin 54, pullspiston 35 rearward withincylinder 123 which is milled in the rear ofhousing 21. Thepiston 35 provides the vacuum for theinjector 20, when applied to the recipient's skin, to pull and stretch the skin tight against thesuction ports 63, in theampule 25, which serves to position theoutlet orifice 66 correctly for injection of the medicament. In addition, the vacuum system includes a safety device to prevent inadvertent triggering of theinjector 20 without first obtaining a good vacuum seal of theampule 25 to the skin. The safety device comprises a smallinterlock piston rod 36, which is adapted to engage and disengage arelease catch 44 in response to a vacuum generated bypiston 35.Interlock piston rod 36 reciprocates within channel 125 and is provided with asmall piston 126 on its rearward end which is located within asmall cylinder 127 communicating with thecylinder 123 ofvacuum piston 35. Thepiston 35 has an O-ring seal 34 that ensures that the piston can produce a vacuum withincylinder 123 for actuation of the smallinterlock piston rod 36. The vacuum provided acts onsmall piston 126 to position the smallinterlock piston rod 36 to engage or disengage therelease arm 55, thereby locking it in a non-release, or unlocking it in a release position. Therelease arm 55 is able to rotate between the two operating positions around apivot pin 54 that interfaces with theinjector housing structure 21 and is biased to the lock position bytorsion spring 33 onpivot pin 54. - A pair of
connector links 47 straddle thevacuum piston 35 and are connected to it bypiston extension 46. Movement of theslide frame 45 drives thevacuum piston 35, and the vacuum created is ported to theampule 25 through asuction tube 71. To release thedrive rod 43, the injector is provided with arelease button 23 which, when pressed, rotates therelease arm 55 aboutpivot pin 54. As therelease arm 55 engagesrelease catch 44, rotation ofrelease arm 55 downward causes releasecatch 44 to pivot upward, releasingdrive rod 43 which is then forced forward bydrive spring 42 so that the forward end ofdrive rod 43 entersampule 25.Release catch 44 rotates aroundlatch pin 58 againsttorsion spring 53. Therelease button 23 is installed in theinjector housing 21 structure so that when pushed inward it contacts therelease arm 55 acting as a cam and causing therelease arm 55 to rotate downward and, in turn, lift therelease catch 43, that locks thecompression spring 42 in its loaded compression position. Therelease button 23 is retained in theinjector housing 21 flush with the housing's outer surface to prevent inadvertent actuation until required by the operating procedure, and is retained in the housing structure with aretention snap ring 32. As noted,release catch 44 includestorsion spring 53 which is tensioned to holdrelease catch 44 in the lock position to hold thedrive rod 43 against thecompressed compression spring 42. An angular end surface ofrelease catch 44 provides a means for contact with a corresponding angular end surface of therelease arm 55 so that, during the release function, therelease catch 44 is pivoted upward around the pivot point provided by thelatch pin 58 that engages thehousing 21 structure asrelease arm 55 is pushed downward bybutton 23. -
FIG. 4 shows a cross section view of theinjector 20 after injection of the medicament and with thehandle 30 rotated away from the housing. To ensure that thedrive rod latch 48 always engages, the driverod retention ring 59, aspring ramp 50 forces the drive rod latch down to engage and lock on to the projectingretention ring 59. The spring ramp is retained by two roll pins 51. To ensure that thedrive rod latch 48 releases at the end of theslide frame 45 travel, thelatch 48 has atorsion spring 53 that is retained by thepin 58, and drives the latch to the release position aroundpivot pin 52. To achieve the vacuum,piston 35 has an annular O-ring seal 34 contained within an annular groove in the surface ofpiston 35 and which engages the wall ofcylinder 123. The vacuum generated bypiston 35 is conveyed to theampule 25 bysuction passages 73 andvacuum tube 71 which is provided with aseal 70 at the point of interface with theampule 25 to ensure the function of suction of the skin at ampule contact for efficient injection of the medicament by the injector. When pressed, the injection release button's 23 lower surface cams down therelease arm 55 and forces therelease catch 44 upward. Therelease arm 55 rotates aroundpivot point 57 that holds thepin 54 andtorsion spring 33. - To ensure that the release arm cannot accidently be rotated by someone pressing on the
button 23 before it is needed and to ensure that the recipient's skin is in contact with theampule 25 ready for injection, theinjector 20 contains a locking feature that prevents the possible release of thedrive rod 43. When thehandle 30 is rotated, movement of thevacuum piston 35 withincylinder 123 creates pressure or vacuum againstsmall piston 126 resulting in reciprocation ofinterlock piston rod 36 between the locked and unlocked positions. Pressure generated withincylinder 123 bypiston 35 ashandle 30 is rotated downward to engagedrive rod latch 48 withretention ring 59, pushesinterlock piston rod 36 forward into the locked position withrelease arm 55. Alternatively, rotation ofhandle 30upward moves piston 35 rearward withincylinder 123 generating a vacuum which, whenampule 25 is against the skin, is sufficient to act againstsmall piston 126 to drawinterlock piston rod 26 rearward, thereby unlockingrelease arm 55. Until there is full suction on the system, theinterlock piston rod 36 is interlocked with therelease arm 55 by engagement of the end ofrod 36 withmating interlock hole 80 inrelease arm 55. In this configuration,release arm 55 is incapable of rotation whenbutton 23 is pressed,release catch 44 cannot be pivoted out of engagement with projecting ring 120 which preventsspring 42 from forcingdrive rod 43 forward intoampule 25 and no medicament can be ejected. Thesmall piston 126 oninterlock piston rod 36 is provided with an O-ring 37 to maintain the vacuum betweenlarge piston 35 and theinterlock piston rod 36. In the space between the two sealed pistons there is asuction port A 38, shown inFIG. 7 , for the transfer of vaccum fromcylinder 123 to theampule 25. To prevent theinterlock piston rod 36 from overtraveling, and to hold it in its correct position for activation by the vacuum, theinterlock piston rod 36 is retained with aretainer ring 39 insmall cylinder 127. To ensure that the largedrive compression spring 42 does not drive thedrive rod 43 hard against an end stop and does not damage theampule 25, thedrive rod 43 bottoms out on acushion washer 75 at the end ofdrive spring chamber 128, when released.FIG. 4 also indicates thesurface 69 that contacts the recipient's skin for injection of the medicament. Theampule 25 is expendable and can be easily installed on the injector assembly by rotating theretainer clamp 22 that is detented 26, on to thehousing 21 of the injector assembly.FIG. 5 shows an end view of the injector assembly andend cap 28, with its attachment screws 76.FIG. 6 provides a cross section view of saidhousing 21, and indicates the two legs of theslide frame 45 as they straddle thevacuum piston 35. -
FIG. 7 provides a sectional view through the housing, and shows the routing and passages through thesuction manifold 72. Themanifold suction passages 73 supply the necessary vacuum for extracting theinterlock piston rod 36 fromrelease arm 55 with a small incoming vacuum for movement of thepiston rod 36 into theinjector assembly 20. The suction manifold system is comprised of machined vacuum ports 129 in the housing structure to receive the vacuum pressure from thevacuum piston 35 and conduct a vacuum through portedsuction passages 73 in the structure within thevacuum piston chamber 123 to theinterlock piston chamber 127 and to thesuction tubes 71 that interface with theampule 25 the suction passages are sequentially opened and closed by positioning of theinterlock piston 126, and a pair of suction tubes that conduct the suction from the machined-in structure suction passages to thesuction ports 63 in theampule 25. - The
injector 20 operating sequence starts by squeezing thehandle 30 without anampule 25 being installed. This causes thedrive rod 43 to be pulled back and latched in the cocked position with thecompression drive spring 42 compressed between projecting ring 120 andannular abutment surface 124 at the rear end ofspring chamber 128. Driverod latch 48, which catches and draws driverod 43 back, is spring loaded up and away fromdrive rod 43 and is only in position to grab thedrive rod 43 when in the full forward position due tospring ramp 50. Ifdrive rod 43 has been released, latch 48 will catch the lip of driverod retention ring 59 and will pull thedrive rod 43 back as thehandle 30 is squeezed.Latch 48 is provided with a notch 125 in its underside for this purpose. Preferably, driverod retention ring 59 has a small concave depression in the forward face to engage the notch 125 ofdrive rod latch 48 and hold it in place while thehandle 30 is squeezed. Upon full retraction ofdrive rod 43 and engagement of projecting ring 120 withrelease catch 44,drive rod latch 48 disengages fromretention ring 59 and is pivoted upward bytorsion spring 53 to clearretention ring 59 whendrive rod 43 is released. - With the
drive rod spring 42 compressed, anampule 25 is slid into position andampule retainer clamp 22 is tightened which bringsampule 25 up againstseals 70 in the bottom of the injector nose with theampule locking tabs 61 engaged with the injector structure. Theinjector 20 is then placed into position with theampule 25 on the patient's skin and thehandle 30 extended. Thehandle 30 is squeezed again. Since thedrive rod 43 is already back in the cocked position, the driverod retention ring 59 will not be in position for thedrive rod latch 48 to catch on when thehandle 30 is extended and squeezed again. As thehandle 30 is squeezed the second time, thevacuum piston 35 creates a vacuum incylinder 123 which is conveyed to suctionports 63 inampule 25 bysuction passages 73 andsuction tubes 71. This vacuum stretches the skin tight against theampule 25 and, when a good seal to the skin is obtained, will cause theinterlock piston rod 36 to retract frominterlock hole 80 inrelease arm 55, thereby releasingbutton 23 for operation. With thehandle 30 squeezed, therelease button 23 is pressed thereby cammingrelease arm 55 downward which liftsrelease catch 44 to disengage from projecting ring 120 thus allowingspring 42 to pushdrive rod 43 into theampule 25 providing the force necessary to eject themedicament 31 from theampule 25 throughorifice 66. Thebutton 23 is then released and thehandle 30 is returned to the extended position thereby releasing the vacuum and allowing the injector to be pulled away from the skin. Simultaneously,interlock piston rod 36 is forced forward to again engageinterlock hole 80 inrelease arm 55 andlock injector 20 against inadvertent operation. Returning to the start position of the operating sequence, the handle is squeezed, thereby latching and pulling thedrive rod 43 back so that the spent ampule can be ejected and replaced with a full one. - A second embodiment of the injector assembly is shown in cross section in
FIG. 8 andFIG. 9 . For convenience and to avoid confusion, like parts are given the same reference numerals throughout where their function and operation are duplicated or repeated. The major difference between the two embodiments is that the former embodiment utilizes manual operation by the rotation of a hand operatedhandle 30, while this embodiment utilizes external air supplied power for some of its functions. As discussed above, the primary embodiment utilizes the manual extending downward and retracting of the handle to actuate alarge piston 35 to create a vacuum that is utilized for ensuring that the recipient's skin is in direct contact with the injector'sinjection orifice 66. This manual mechanism also actuates a means for preventing accidental activation of the injector and a means for compressing theimpulse drive spring 42 to a lock position, ready for release by the operator pushing downward on theactivation button 23. In this second embodiment of the invention, an external source of pressurized air provides a means whereby the mechanical operations of cocking thedrive spring 42 and driverod 43, generating a vacuum and activating and deactivating the locking safety mechanism are substantially automated so as to occur in response to movement of a trigger assembly 89. The vacuum assist is achieved by the operation of a valve 100 that is controlled by a trigger assembly 89. Movement of the trigger one way, opens the valve for pressure to travel up to alarge return piston 83 inextension housing 102 on the rear end ofinjector housing 21, that pulls back on thevacuum piston 35 to create a vacuum and initiate the same functions achieved by the previous handle movement, connection of thereturn piston 83 to thevacuum piston 35 being by means of connectingrod 82 passing through the end wall ofextension housing 102. Activation of the trigger in the opposite direction closes off the outside pressure source and, in turn, shuts down the vacuum assist function provided by thereturn piston 83.FIG. 8 andFIG. 9 show this new embodiment in two positions during the injection operation. This embodiment of the needle-free jet injector utilizes external air pressure for activating and sequencing the injector components. Theinjector 20 is provided with a trigger assembly 89 that is operated by the operator's finger for initiation and movement of an air valve 100 in theinjector 20, that opens and blocks externally supplied air pressure from exterior source entering through fitting 49 to alarge return piston 83 that is, in turn, connected to thevacuum piston 35 by connectingrod 82. Thevacuum piston 35 functions as described in connection with the previous embodiment and provides the vacuum for interlock functions of therelease button 23 and therelease catch 44 to initiate injection of the medicament. Thevacuum piston 35 is moved by thereturn piston 83 to create a vacuum at the interface contact surface of the recipient's skin and theampule 25 containing the medicament The trigger assembly 89 is operated by the injector operator's finger applying a squeezing motion to move the trigger 89 upward, toward the injector activation frame 87 thereby causing the trigger assembly 89 to push against apush rod 90 which actuates a valve 100 to sequence air pressure to enter the injector from the outside air supply through source fitting 49. Thepush rod 90 travels fore and aft in a machined support fitting 95 that is attached to the underside of the injector assembly and is retained within the support fitting 95 by a threadedbushing 105 at the end adjacent to the trigger 89 which provides a means for sealing and retention of the air pressure within the support fitting 95. An O-ring seal 92 is captured between thebushing 105 and the support fitting 95, and seals around thepush rod 90 where it passes through thebushing 105 and contacts the trigger assembly 89. A like O-ring seal 92 seals around thepush rod 90 and seals against the support fitting 95 at the opposite end adjacent to the valve 100. Valve 100 reciprocates in response to fore and aft movement ofpush rod 90 and is used to sequence the incoming air pressure that enters thevalve cavity 130 through twocross pressure ports 91 from the air supply. The valve 100 blocks and opens passage for the incoming pressure to travel into the injector assembly. The valve seals against an O-ring 101 in one direction and seals against the previous O-ring 92 in the opposite direction. Thepush rod 90 is machined with an undercut 131 to permit air to travel to the valve 100, which than can allow it to pass up into theinjector 20, or to be blocked by the valve 100 and its seal. The position of the valve 100 is controlled by the position it is put in by the trigger assembly 89. When the trigger assembly 89 is not activated, the valve 100 is positioned in the air blocked or closed position by a compression spring 99 that is captured by a spring retention plug 98 threaded into the support fitting 95. When the valve 100 is in the blocked or closed position any air pressure captured in the injection on the opposite side of the valve is bled out of the return spring cavity though apressure bleed hole 97. An O-ring seal 96 is installed at theinterface air passage 132 joint between the support fitting 95 andextension housing 102 attached to the injector assembly. Theair passage 132 conveys pressurized air from valve 100 intoextension housing 102 to drivelarge return piston 83 that is connected to thevacuum piston 35 by a connectingrod 82. Air pressure behind thereturn piston 83 pulls on the connectingrod 82 and, in turn, moves theslide frame 45 to accomplish what the handle enacted within the prior injector assembly. Thereturn piston 83 has an O-ring 84 for piston sealing and acompression spring 85 located betweenreturn piston 83 andspring retention cap 94 for the return function of thereturn piston 83. Thecompression spring 85 is captured in apocket 133 in the return piston and in apocket 134 in thespring retention cap 94. Air captured between theretention cap 94 and thereturn piston 83 is bled out of the cavity through ableed hole 97. Theretention cap 94 is attached to the end ofextension housing 102 with retention screws 86. The air pressure into the pressure side of thereturn piston 83 enters through a port 135 machined in theextension housing 102 and connecting withair passage 132.Plug 93 closes the end of port 135 intovacuum piston cylinder 123. Theextension housing 102 is provided with an O-ring seal 81 for sealing pressure aroundconnection rod 82 and preventing air bleed intovacuum piston cylinder 123. - Whereas in the manual embodiment of the
injector 20drive rod 43 is a single piece, the present embodiment includes an alternative structure where thedrive rod 43 is divided into two sections, driverod portion 43′ and driverod portion 43″, with an absorbing spring between them. The rearward portion, driverod 43′ includesretention ring 59 withcompression drive spring 42 surrounding the shaft betweenretention ring 59 and adrive cylinder 78 at the forward end ofdrive rod portion 43′. Separated fromdrive cylinder 78 is forwarddrive rod portion 43″ which entersampule 25 when injection occurs. To ensure thatdrive rod portion 43″, when driven by thelarge drive spring 42, does not unduly impact theampule plunger 65 and cause a problem on injection of the fluid, asmall compressing spring 77 is installed between the rearward end of forwarddrive rod portion 43″ and thedrive cylinder 78. This compressingspring 77 ensures that the end of thedrive rod portion 43″ is in constant contact with theampule plunger 65 prior to and during injection, thereby avoiding a hard impact betweendrive rod portion 43″ andampule plunger 65 when the injector is initiated. Compressingspring 77 absorbs the initial shock whenrelease catch 44 is rotated to release position and thetooth release catch 79 disengages with thedrive cylinder 78 releasingdrive spring 42. The result is that the force of thedrive rod portion 43″ onampule piston 65 is constant and the medicament fluid is driven out of theampule 65 with a smooth high energy force supplied by thelarge drive spring 42. This alternative, twopart drive rod 43 may also be applied to the previous manual embodiment of the injector.FIGS. 10A and 10B provide views showing the connection of the external air supply to the injector and the related manifolding of air passages in the injector. - In a further alternative, the functions of the foregoing pneumatic system may be achieved with an electronic solenoid, or similar electrical or electromagnetic device, powered by batteries or other electrical source. In such an alternative, the solenoid would occupy the space in
extension housing 102 in place of thepneumatic piston 83, the plunger of the solenoid being attached to connectingrod 82. A battery pack providing power for the solenoid may be located under thehousing 21 in place of support fitting 95, and electrically connected to the solenoid through a switch operated by the trigger assembly 89 or a switch located elsewhere on thehousing 21. The operational steps of such an alternative would be the same as the pneumatic embodiment described herein. - Although the preferred embodiment of the injector employs the mechanical compression spring and latch mechanisms to provide the driving force of the impact impulse mechanism, it is certainly within the scope of the present invention to provide the injector in a form that is totally pneumatically or electronically operated. In such modifications, the compression drive spring and mechanical cocking and latching mechanisms would be replaced by equivalent pneumatic and electrical, electronic or electromagnetic actuators to drive both the
drive rod 43 and thevacuum piston 35. - In a totally pneumatic alternative, the chamber in which the
drive rod latch 48 operates to engage theretention ring 59 on the end of thedrive rod 43 would be modified to form a pneumatic cylinder withretention ring 59 modified to form a pneumatically actuated piston withdrive rod 43 attached. Appropriate porting would be provided for directing a pneumatic fluid, such as compressed air, to either side of the piston in response to actuation of an appropriate valve, thereby reciprocating the pneumatic piston and thedrive rod 43. In addition, means to adjust the pneumatic force may be included thereby providing adjustment of the driving force ofdrive rod 43 againstplunger 65 for intradermal, subcutaneous or intramuscular injections. - In a totally electronically operated injector it would be a simple matter to replace the
drive spring 42 with an electronic or electromagnetic actuator, such as a push-pull solenoid, wheredrive rod 43 forms the reciprocating core. In this alternative, actuation of the solenoid would result in reciprocation of thedrive rod 43. With a variable power solenoid and appropriate voltage regulating means, the driving force generated by the solenoid may be adjusted for subcutaneous, intradermal or intramuscular injections. - Turning now to the
ampule 25, this is a key element of the injector device of the present invention as it is the part which holds the medicament to be injected and interfaces with the injector to apply suction generated by the injector to the skin in order to draw the skin tight for proper injection. Theampule 25 further interfaces with the injector to provide proper functioning of the safety interlock in the injector since release of the interlock requires establishing a fill suction on the system which cannot be achieved without theampule 25. With theampule 25 andinjector 20 combination of the present invention it is now possible to achieve needle-less injection of medicament intradermally, subcutaneously or intramuscularly at any angle relative to the surface of the skin. - The basic disposable, pre-filled ampule of the present invention is shown in
FIGS. 11, 12 and 13 and provides containment for the medicament and means for attachment to the injector and interface with the vacuum system. Theampule body 67 is preferably made of plastic, glass or equivalent materials or combinations thereof that are suitable for medical use, and is provided with a cylindrical or other shape borechamber 62 for containing the medicament Dosage markers 141 are provided on the side of theampule 25 at thechamber 62 to indicate the amount of medicament in thechamber 62. At the forward end of thebore chamber 62 is theoutlet orifice 66, while the rear end of thechamber 62 is closed with an internalampule plunger seal 65 that captures the medicament inside its chamber. Theplunger seal 65 is contacted by thedrive rod 43 when the injector is actuated and is pushed forward within thechamber 62 to eject the medicament through theorifice 66. - The shape of the
ampule 25 is significant for proper functioning of the injector system, particularly for achieving intradermal injection. In that respect, thebody 67 of theampule 25 is structured such that thenose portion 136 is thinner than thebore chamber portion 137, resulting in a vertical offset 138, or step face, to the lower surface of theampule 25 as shown inFIG. 11 and 13. This offset 138 effectively creates a pocket 139 in front of theorifice 66 into which the skin surface can be readily drawn by suction from the injector applied throughsuction ports 63. In addition, the offset 138 of the lower surface permits ampules to be formed for intradermal, intramuscular and subcutaneous injection that can be used with thesame injector 20 simply by changing the thickness of thenose portion 136 of thebody 67 while the position of thebore chamber 62 relative to the upper surface of thebody 67 remains the same. Thus, an ampule with athin nose portion 136 will have a greater offset 138 such that the effective level of thechamber 62 will be deeper and more suited to subcutaneous or intramuscular injection, whereas a thicker nosed ampule will have a lesser offset 138 and be suitable for intradermal injection. In this manner, the different ampules can be used with the same injector since thedrive rod 43 of the injector and theplunger seal 65 in thebore chamber 62 will always be at the same relative height. This relationship can be seen by comparingFIG. 24 , which shows anampule 25 with athick nose portion 136 being used for intradermal injection, withFIG. 26 , which shows anampule 25 with athin nose portion 138 being used for subcutaneous injection. - In a further embodiment, the underside of the ampule immediately surrounding the lower end of the
suction ports 63 is preferably formed with a depression or well 140 with the end of thesuction port 63 located at the deepest point. This well 140 improves the effect of the suction against the skin and assists in achieving lift of the skin into the pocket 139. It is particularly advantageous for intradermal injections. In ampules having asingle suction port 63, the well 140 is preferably circular, whereas in ampules with two ormore suction ports 63,individual wells 140 can be formed with eachport 63 or asingle well 140 accommodating allports 63 in the ampule can be formed as shown inFIG. 12 . -
FIG. 12 shows a plan view of the underside of anampule 25 with twosuction ports 63 and asingle well 140 encompassing both ports.FIG. 13 shows a longitudinal cross-section view of theampule 25 with thechamber 62 contoured 68 on its inner surface to provide a precision throat to aid in acceleration of the medicament by reduction of the fluid drag when theampule 25 receives an impact impulse from the spring loadeddrive rod 43 of theinjector 20. This reduction of the fluid drag increases the acceleration of thepiston 65 resulting in a faster pressure rise and injection of the medicament for the relative force of thecompression drive spring 42. Therefore, themedicament 31 is driven out of theampule 25 with a known controlled impact impulse force. - In addition to the difference in offset 138 resulting from the relative thickness of the
nose portion 136 of theampule body 67, the position and location of theorifice 66 center line relative to theunderside plane 69 of thevacuum port 63 can be varied further tailoring the ampules for interdermal, subcutaneous or intramuscular injection medicaments. This also allows injection horizontally or vertically or at any variation of angle therebetween, whether laterally or skewed, through human or animal skin to predetermined depths in theskin layer 64, the dispersement of the medicament in injections being controlled by variation of the angle of theorifice 66 to the vacuumport level plane 69 and the centerline of the ampule. In addition, multiple orifices can be provided to facilitate injection of larger doses or wider injection patterns. As noted previously, theampule 25 includes lockingtabs 61 on each end for engagement with and latching to theinjector 20. The lockingtabs 61 also serve to correctly position and retain theampule 25 on theinjector 20 for accurate engagement of thesuction ports 63 with thevacuum suction tubes 71 and alignment of thedrive rod 43 with thechamber 62 andplunger 65. The interface between the surface of the ampule and thesuction tubes 71 is sealed byvacuum port seal 70 so as to ensure proper suction throughports 63 to engage recipient's skin for stretching theskin 64 betweenports 63 for the medicament injection into recipient'sskin 64. - In addition to being prefilled, the
ampule 25 may be filled withmedicament 31 from an external supply by use of an adaptor assembly 103, shown inFIG. 14 , that holds theampule 25 and seals it for filling the medicament through arubber seal 104 in the adaptor that aligns with and permits filling ofampule 25 through itsorifice 66. The adaptor 103 comprises a housing having means to receive and hold theampule 25 so that theorifice 66 is in registration with apassage 115 through therubber seal 104. Astandard Luer connector 142 provides a means for attachment of a filling syringe. - An alternative ampule embodiment incorporating means to permit direct filling of the
bore chamber 62 with medicament is shown inFIGS. 15 through 18 . In this embodiment, the ampule is provided with a fillingport 143 in the upper surface of theampule 25 that is closed by aresealable rubber stopper 106. -
FIG. 16 shows anunfilled ampule 25 in which fillingport 143 connects withbore chamber 62 throughpassage 115. Aplug 118 closesorifice 66 andprotective coverings -
FIG. 17 shows the operation of filling the ampule of this embodiment. In this operation, a probe 111 on a nozzle 110 is inserted through thestopper 106 in the fillingport 143 of theampule 25. The nozzle 110 includes a shoulder stop 116 that bears on the upperflat surface 114 of theampule 25 and locates the probe 11 correctly for the medicament filling. Air must first be evacuated from theampule passage 115 and theair space 113 within theampule 25. This is accomplished with the use ofsyringe 109 and its retraction handle 112 to draw the air out prior to filling theampule 25 with the medicament. Removal of the probe 111 allows theplug 106 to reseal thereby sealing off thepassage 115 andspace 113 containing the vacuum. The probe 111 of a nozzle 110 on asyringe 109 containing medicament, or theoriginal syringe 109 now containing medicament, is reinserted through thestopper 106 and the is used to fill theampule 25 with a prescnbed medicament after air evacuation. The pressure of the medicament being injected through probe 11 andpassage 115 intospace 113, pushesplunger 65 rearward inbore chamber 62. -
FIG. 18 shows a means for plugging of theampule orifice 66 with aplug 118 when filling the medicament. Plug 118 contains anenlarged head 119 for ease of installation and removal with acapture pad 117 to seal against the surface of theampule 25 and to prevent theplug 118 from being sucked into theorifice 66. A protective outer doubler covering 121 serves as a means to prevent theplug 118 from being driven out of theorifice 66 during filling. All other openings in theampule 25 are protected withcoverings ampule 25 and provide for removal and disposal of theampule orifice plug 118 whenprotective covering 108 is removed. Preferably,protective coverings ampule 25. - Referring to the drawings, the preferred embodiment of the invention illustrated in
FIG. 1 andFIG. 2 shows the envelope of the needle-free injector top view and side-view respectively. Theinjector assembly 20 comprises ahousing 21 that holds the injector assembly components which are actuated by anexternal handle 30 and arelease button 23, shown in the top view.FIG. 2 illustrates the means for installation of the medicament filledampule 25 into theinjector 20 and providesaccess panel 27,end cap 28, and insert fairing 74 as removable units for assembly and service of the injector. -
FIG. 3 andFIG. 4 provide a cross section view of the injector assembly with thehandle 30 in both a rotated up and a rotated down position and the resultant position of all of the components contained in thehousing 21 respectively. This embodiment covers the use of asingle prefilled ampule 25 and shows how it is captured in the injector assembly. Theampule 25 has projectingtabs 61 that engage a notched cavity in the insert fairing 74 at one end are and positioned and retained against the nose of thehousing 21 at the other end withretainer clamp 22 that pivots outward away from theampule 25 to release it and provide for replacement after theampule 25 has been used. Theampule 25 includes at least onevacuum suction port 63 for interfacing with the injection recipient's skin. Theampule 25 installation in theinjector 20 positions theampule 25 under and against aseal 70 that provides sealing between theampule 25 and a pair ofsuction tubes 71 that are utilized to convey a vacuum to theampule vacuum ports 63. Thesuction tubes 71 at their opposite ends interface with a machined-inmanifold 72 in thehousing 21. Theampule retainer clamp 22 is retained in the ampule capture position with a detent projection on the retainer clamp that engages a small pocket in thehousing 21 and, when theretainer clamp 22 is in the ampule retention position, theclamp 22 snaps into the pocket for firm retention. On release of theclamp 22 it is rotated around the upper detent pocket for ampule removal. - To eject
medication fluid 31 out of theampule 25, adrive rod 43 travels in a bored hole in thehousing 21 structure and is driven into a chamber opening in saidampule 25 contacting aplunger 65 therein to force under pressure the fluid out of theampule 25 through anorifice 66. Thedrive rod 43 is driven into theampule 25 by a largecompression drive spring 42 that applies load against a projecting ring 120 on thedrive rod 43 and at the opposite end against anabutment surface 124 of the housing structure. To compress thedrive spring 42, the injector assembly is provided withhandle 30 that stradles the assembly and pivots around a pinnedpivot 24. When thehandle 30 is rotated up toward thehousing 21, thecompression spring 42 is compressed and is retained at the preloaded compressed location by arelease catch 44 that pivots around apin 58 containing atorsion spring 53. Thetorsion spring 53 preloads therelease catch 44 down to readily latch thedrive rod 43 when the projecting drive rod ring 120 passes by thetooth 79 ofrelease catch 44. - To compress the
compression spring 42 that encircles thedrive rod 43, thedrive rod 43 also has, at its rearward end termination,retention ring 59 that is used bydrive rod latch 48 to pull on thedrive rod 43 and compress thecompression spring 42 in response to upward rotation of thehandle 30. To achieve this compression and loading up of thecompression spring 42 when thehandle 30 is rotated upward, thehandle 30 connects to alink 40 that has pivot points 41 and 60 at each end and connects to slideframe 45 that slides in machined grooves in thehousing 21. Theslide frame 45 is moved horizontally in the grooves by thehandle 30 pushing thelink 40 that in turn moves theslide frame 45.FIG. 3 andFIG. 4 illustrate the two positions of theslide frame 45 and thehandle 30. An upright leg on theslide 45 is attached to thedrive rod latch 48 that is used to pull thedrive rod 43 andcompression spring 42 to the compressed loaded energy stored condition. Thedrive rod latch 48 pivots around apivot point pin 52 that holds and engages a connectinglink 47 and atorsion spring 53 that biases thedrive rod latch 48 upward to the unlatched position to ensure thatdrive rod 43 will be released when theinjector 20 is actuated. - To ensure that the
drive rod latch 48 will rotate downward against the torsion spring load thedrive rod latch 48 is guided down to the latched lock position with aramp 50. Theramp 50 is retained in thehousing structure 21 with two roll pins 51 and theramp 50 is sloped to match the angular end termination of thedrive rod latch 48. Thedrive rod latch 48 includes a projecting hook surface on the opposite side of the latch to catch and hold the driverod retention ring 59 for pull back. The driverod retention ring 59 preferably has a concave depression in the forward face to ensure that the projecting hook of thedrive rod latch 48 will stay engaged while thehandle 30 is squeezed to pull thedrive rod 43 back. When therelease catch 44 is released, thecompression spring 42 drives thedrive rod 43 into theampule 25 and injects the fluid out of theorifice 66 in theampule 25. To minimize impact noise of the drive rod projecting ring 120 andcompression spring 42 striking an end stop, the forward side of the drive rod projecting ring is provided with a plastic orrubber washer 75 for noise deadening purposes. - The
connector link 47 that is connected to theslide frame 45 is connected at its opposite end to apin 54 that engages anextension 46 on apiston 35 that provides a vacuum for theampule vacuum ports 63. When theslide frame 45 is moved horizontally in the machined grooves in the housing structure, the connectinglink 47 moves the piston in and out in itscylinder 123. To achieve a vacuum behind thepiston 35, thepiston 35 includes an O-ring seal 34. The vacuum created is transmitted throughsuction passages 73 in thestructural manifold 72 to thesuction tubes 71 and, in turn, to thevacuum ports 63 in theampule 25 as shown inFIG. 7 . The vacuum created by the movement of thepiston 35 retracts aninterlock piston rod 36 that provides a means for locking and unlocking arelease arm 55. Two vacuum port openings in the manifold 72 cycle theinterlock piston rod 36 back and forth when interlock is required. Theinterlock piston 126 is provided with an O-ring seal 37 and aretainer ring 39 controls the length of its movement stroke and captures it in itscylinder 127. - The
interlock piston rod 36 extends into therelease arm 55 for locking and retracts out of therelease arm 55 for unlocking. Therelease arm 55 pivots about apivot pin 54 that includes atorsion spring 33 that positions thearm 55 for engagement with thepiston rod 36. When therelease arm 55 is in the horizontal position, as the result oftorsion spring 53 load, therelease arm 55 rests against the bottom surface of arelease button 23 that is held in thehousing 21 with asnap ring 32. When therelease button 23 is pressed down by the operator it presses down on therelease arm 55 and rotates it, which in turn drives therelease catch 44 upward to disengage from thedrive rod 43, which is then driven into theampule 25 by thecompression spring 42 and injects the medicament into the skin tissue of the recipient. - The
ampule 25 is illustrated inFIG. 11 side view andFIG. 12 shows a top view of theampule 25. Theampule 25 is manufactured from one or more of a variety of plastics, or glass, or equivalent medical grade materials. Theampule 25 has at least onevacuum port 63 for use in positioning, stretching and holding the recipient'sskin 64. Theampule 25 further has at least two lockingtabs 61 and an internal cylinder borechamber 62 for containment of the preloaded medicament. Dosage markers are provided on the outer surface of theampule 25 adjacent to thebore chamber 62. Contained within thebore chamber 62 is anampule plunger 65, shown inFIG. 11 that captures and contains the medicament within thebore chamber 62 and transfers the force of thedrive rod 43 to the medicament to eject the medicament from theampule 25 through theorifice 66. Thebore chamber 62 is preferably contour shaped 68 to enhance the injection process. Theampule 25 and theinjector 20 are unique in that theampule 25 uses a vacuum produced by theinjector 20 to stretch and properly hold the recipient's skin for the medicament to be injected into the skin. Stretching the skin increases permeability which reduces the amount of energy required to inject fluid into a tissue. Injecting the fluid horizontally to the skin allows controlled positioning of the tissue for ID, Sub-Q and IM injections. Thebore 62 andorifice 66 are designed to accelerate the fluid with minimal drag by arefined throat contour 68. The size and length of the ampule's bore are also optimized to minimize turbulent flow and thus drag and this will reduce pain and energy required to penetrate the epidermal tissue. This process of injection of medicament fluid into the tissue spreads the particles of the medicament over a larger area than using a needle syringe and, in turn, decreases the local pressure in the tissue and eliminates leakage of the fluid from the injection opening in the tissue, which in turn reduces possibility of spreading infections. - A further embodiment of the invention is illustrated in
FIG. 19 which shows the side view of theinjector 20 of the present invention adapted to receive and fitted with amultiple ampule assembly 200. The function, operation and internal components of theinjector 20 are the same as those presented previously in the said single ampule embodiments with the exception of the ampule, its attachment to and retention on theinjector 20 and the technique of ampule replacement.FIG. 12 illustrates a cross section view of the multiple ampule injector assembly with manual embodiment single ampule injector components. The air powered embodiment may be similarly modified to receive themultiple ampule assembly 200. Since the mechanical operation of the manual and airpowered injectors 20 is the same as described previously herein, the description thereof will not be repeated except as necessary to for a clear understanding of the multiple ampule embodiment. - The multiple
ampule injector housing 201 comprises a rotatablemultiple unit cartridge 205 that contains multiple medicament filledampules 25 molded into a plastic or equivalent material cylinder 222 as shown inFIG. 21 andFIG. 22 . The cylinder 222 is rotatable around acenter shaft 206 as shown inFIG. 20 andFIG. 21 . The cylinder 222 is manually rotated by arotation knob 208 rotatably attached to the end of theshaft 206. Thecartridge 205 containing theampules 25 is keyed to theshaft 206 by asleeve 209 to provide a means for rotation and positioning of theampules 25 for fluid injection. Aposition detent 207 is installed in theinjector housing 21 and positions and detents into a series ofpockets 204 in the rim of thecartridge 205. In addition, asimilar detent 214 in theinjector housing 21 engages anannular groove 213 adjacent to the end of theshaft 206 to capture and hold themultiple unit assembly 200 on to the end of theinjector 20. Preferably thedetents ball 215 and spring 216 mechanisms as shown, but other detent mechanisms providing similar function may be used. - The
rotation knob 208 is keyed and retained on thesleeve 209 with aknob capture pin 223 so that when the knob is rotated it rotates thecartridge 205 in thehousing 201 around theshaft 206 but does not rotate theshaft 206 itself. Thesleeve 209 attached to theknob 208 keys in thecartridge 205 and turns it to the various ampule positions whereupon theposition detent 207 engages thepocket 204 for that position and holds theampule 25 in registration with thedrive rod 43. - In the
cartridge 205 of themultiple unit 200 each ampule 25 contains a set ofvacuum ports 203, preferably two, but at least one, and an internal cylinder borechamber 62 for containment of the preloaded medicament. As with the single ampule embodiment, eachampule 25 of themultiple unit 200 is provided with dosage markers on its outer surface. Also, eachampule 25 contains within itsbore chamber 62 anampule plunger 212 that captures and contains the said medicament. Similarly, thebore chambers 62 duplicate the contour shape, size, length and configuration as presented in the prior single ampule embodiment and, therefore, the injection procedure, method of injection and results of the injection are identical. - The
multiple unit assembly 200 contains asimilar suction tube 210 and aseal 211 for interface with each ampule that is positioned for fluid injection. A stepped surface on the cartridge'ssleeve 209 bears down on thesuction tube 210 to enhance theseal 211 interface between thesuction tube 210 and theampule 25. Thesuction tube 210 connects to the injector's manifold system in a manner identical to the previous embodiments. - On the outside surface of the
multiple unit housing 201 there is awindow 221 that reveals by means of anelectronic code 219 and sequential number 222, the status of thevarious ampules 25 in thecartridge 205. This data reveals the medicament and the dose used, date of filling, name of the supplier laboratory and/or other pertinent information. As with the single ampules, each individual ampule of the multiple unit may be protected by aremovable tab 220 prior to use. - In use, a multiple
unit ampule assembly 200 having the desired medicament preloaded in theampules 25 will be selected and installed on theinjector 21 by insertion of the end ofshaft 206 into a blindshaft receiving hole 218 bored in the end ofinjector housing 21 untildetent 214 engages thegroove 213 in the end ofshaft 206, thereby holdingmultiple unit assembly 200 in place. The engagement ofdetent 214 and groove 213 is of sufficient strength to holdmultiple unit assembly 200 in place against inadvertent displacement, but not so strong that themultiple unit assembly 200 cannot be readily removed for replacement anotherassembly 200. With themultiple unit assembly 200 in place,knob 208 is rotated to bring an ampule into position and the injector is operated as previously described. To ready the injector for the next injection using the samemultiple unit assembly 200, one simply re-cocks the injector as has been described thereby withdrawing the drive rod from the now usedampule 25 and rotates theknob 208 to bring the next ampule into position. When all ampules in the multiple unit have been depleted, or if a different multiple unit is desired, one grasps thehousing 201 of themultiple unit 200 and pulls it from the injector. - While there have been described above the principles of this invention in connection with specific methods and apparatus, it is to be clearly understood that this description is simply illustrative and numerous other arrangements may be devised by those skilled in the art, which will embody the spirit of the invention and which fall within the scope of the following claims.
Claims (29)
1. A needle free hypodermic injector comprising:
a hand manipulatable elongated housing,
an impact impulse injection mechanism within said housing,
a suction generating means within said housing and cooperable with said impact impulse injection mechanism,
a safety interlock mechanism,
at least one medicament containing ampule cooperable with said impact impulse injection mechanism and said suction generating means and having at least one jet orifice through which medicament is injectable through a skin surface in response to an impulse placed on said medicament by said impact impulse injection mechanism, and
means to receive and hold said ampule on said injector in registration with said impact impulse injection mechanism and in communication with said suction generating means,
whereby said injector is adapted to expel said medicament from said ampule in a jet stream of sufficient velocity to penetrate skin tissue held against said orifice by said suction generating means and to deposit said medicament intradermally, subcutaneously or intramuscularly based on the position and angle of said jet orifice and the force provided by said impact impulse injection mechanism.
2. The needle free hypodermic injector of claim 1 wherein said ampule comprises an elongated body having a forward end, a rearward end, a substantially planar upper surface and a lower surface having a downward offset between said forward end and said rearward end, said offset providing a forward facing step face, a horizontally disposed bore within said body extending from the rearward end of said body to a point substantially adjacent to said step face, said bore being open at said rearward end and having a sealing plunger disposed therein, said bore further having at least one jet orifice extending through said step face, whereby said bore is capable of holding a quantity of medicament injectable through a skin surface held against said orifice in response to said plunger being driven forward in said bore by said impact impulse injection mechanism.
3. The needle free hypodermic injector of claim 2 wherein said ampule further comprises at least one suction port extending vertically through said body from said upper surface to said lower surface at a point forward of said step face, said suction port being in fluid communication with said suction generating means whereby a suction generated by said suction generating means is applicable to said skin surface through said port whereby said skin surface is drawn against said lower surface of said ampule and said jet orifice prior to injection of said medicament.
4. The needle free hypodermic injector of claim 3 wherein said impact impulse injection mechanism comprises:
a drive rod linearly reciprocatable within said housing between a cocked position and an injection position and having a forward portion adapted to project from said housing into said ampule bore to contact and drive said plunger upon movement of said drive rod from said cocked position to said injection position,
a compressible drive spring concentrically disposed along a rear portion of said drive rod between a stationary abutment and a projection substantially midway along said drive rod,
a releasable latch mechanism adapted to engage said projection and hold said drive rod in said cocked position with said spring compressed, and
a cocking mechanism adapted to draw said drive rod rearward to said cocked position,
whereby actuating said cocking mechanism draws said drive rod rearward in said housing compressing said drive spring between said stationary abutment and said projection and positioning said drive rod such that said latch mechanism engages said projection thereby holding said drive rod in said cocked position ready for injection and releasing said latch mechanism allows said spring to decompress thereby driving said drive rod forward to engage said plunger in said ampule and drive said plunger against said medicament whereby said medicament is forced through said orifice and injected into said skin surface.
5. The needle free hypodermic injector of claim 4 wherein said suction generating means comprises a reciprocating piston disposed in a cylinder in said housing, said piston being mechanically connected to said cocking mechanism whereby said piston is moved in said cylinder concurrently with cocking of said drive rod thereby creating a suction behind said piston, and means providing fluid communication between said cylinder and said ampule whereby said suction is conveyed from said cylinder to said ampule suction port.
6. The needle free hypodermic injector of claim 5 wherein said safety interlock mechanism comprises a reciprocating rod responsive to said suction and adapted to engage said latch mechanism in response to incomplete suction applied through said ampule suction port to said skin surface, whereby said latch mechanism is prevented from operating to release said drive rod and drive spring from said cocked position in the absence of secure contact of said ampule with said skin surface.
7. The needle free hypodermic injector of claim 3 further comprising a concave depression in said lower surface of said ampule surrounding and concentric with said suction port, whereby a suction generated by said suction generating means is applicable to said skin surface through said port whereby said skin surface is drawn against said lower surface of said ampule into said depression and against said jet orifice prior to injection of said medicament.
8. The needle free hypodermic injector of claim 7 wherein said jet orifice is located in said step face adjacent to an upper edge thereof and horizontally along a centerline of said bore whereby said ampule is adapted for intradermal injection of medicament.
9. The needle free hypodermic injector of claim 7 wherein said jet orifice is located in said step face at a downward angle relative to a centerline of said bore whereby said ampule is adapted for subcutaneous or intramuscular injection of medicament.
10. The needle free hypodermic injector of claim 2 wherein said ampule further comprises two suction ports laterally spaced on opposite sides of a center line of said ampule and extending vertically through said body from said upper surface to said lower surface at a point forward of said step face, said suction ports being in fluid communication with said suction generating means, said ampule further comprising a concave depression in said lower surface encompassing the lower ends of said suction ports, whereby a suction generated by said suction generating means is applicable to said skin surface through said ports whereby said skin surface is drawn against said lower surface of said ampule into said depression and against said jet orifice prior to injection of said medicament.
11. A needle free hypodermic injector comprising an injector assembly and at least one medicament containing ampule removably attachable to said injector assembly, said injector assembly comprising an elongated hand manipulatable housing, said housing comprising:
a main body portion containing a mechanical impact impulse means comprising a drive rod linearly reciprocatable within said housing between a cocked position and an injection position, a compressible drive spring linearly concentric about a rear portion of said drive rod, said spring being confined between a stationary abutment within said housing and a projection substantially midway along said drive rod whereby rearward displacement of said drive rod compresses said spring, a latch mechanism cooperating with said projection to releasably hold said drive rod in a cocked position wherein said spring is compressed, a release means to release said latch mechanism when injection is desired, and a cocking means cooperating with said drive rod and operable to draw said drive rod in a rearward direction to said cocked position thereby compressing said spring and engaging said latch mechanism;
a forward nose portion adapted to removably receive said at least one ampule and having detent means to releasably secure said ampule to said injector assembly when said impact impulse mechanism is in said cocked position, said at least one ampule comprising a body having a forward end and a rearward end, a substantially planar upper surface and a stepped lower surface having a forward facing step face therein, said body having formed therein behind said step face a horizontally disposed substantially cylindrical medicament chamber open at said rearward end and narrowing to at least one jet orifice in said step face, said chamber being sized and positioned to receive a forward end of said drive rod when said ampule is secured to said injector assembly and said latch mechanism is released, said chamber further containing a sealing plunger providing a means to retain medicament in said chamber, said plunger adapted to be engaged by said drive rod upon release of said latch mechanism, whereby said drive rod drives said plunger forward within said chamber forcing said medicament under pressure through said jet orifice for injection into a skin surface held against said ampule.
12. The needle free hypodermic injector of claim 11 further comprising at least one suction port vertically disposed through said ampule body forward of said jet orifice, a suction generating means disposed in said main body portion of said housing and suction conduits within said housing and said nose portion providing fluid communication between said suction generating means and said at least one suction port whereby suction generated by said suction generating means is conveyed to said at least one suction port of said ampule, said suction serving to draw said skin surface against said ampule and said orifice prior to injection.
13. The needle free hypodermic injector of claim 12 wherein said suction generating means comprises a piston reciprocatable within a cylinder in said housing, said piston being connected to and operable by said cocking means to generate said suction.
14. The needle free hypodermic injector of claim 13 further comprising a suction operated interlock adapted to lock said latch mechanism against inadvertent operation in response to insufficient suction applied to said skin surface, said interlock comprising a piston operating within a cylinder adjacent to said suction generating means and fluidly connected thereto by said suction conduits, said piston having a locking rod projecting longitudinally therefrom, said locking rod having an end remote from said piston adapted to engage said latch mechanism when said interlock is in said locked position and to disengage from said latch mechanism when sufficient suction is applied to the skin through said ampule thereby permitting release of said drive rod and spring from said cocked position whereby said drive rod moves forward to engage and drive said plunger within said ampule chamber.
15. The needle free hypodermic injector of claim 14 wherein said cocking means comprises a handle pivoted to said housing, a slide frame within said housing mechanically connected to said handle so as to reciprocate within said housing upon pivoting of said handle, a drive rod latch attached to said slide frame and adapted to engage said drive rod when said handle is pivoted away from said housing and to draw said drive rod rearward against the force of said compression drive spring when said handle is pivoted toward said housing, said drive rod latch being biased to disengage from said drive rod upon engagement of said latch mechanism, and a mechanical link between said slide frame and said piston of said suction generating means whereby said piston is moved within said cylinder when said handle is pivoted and generates a suction at said ampule when said handle is pivoted toward said housing.
16. The needle free hypodermic injector of claim 14 wherein said cocking means comprises a pneumatically operated piston within said housing, a source of compressed air, air conduits, a trigger operated valve, a slide frame within said housing mechanically connected to said pneumatically operated piston so as to reciprocate within said housing upon actuation of said piston, a drive rod latch attached to said slide frame and adapted to engage said drive rod when said pneumatically operated piston is driven in a first direction and to draw said drive rod rearward against the force of said compression drive spring when said pneumatically operated piston is driven in a second direction, said drive rod latch being biased to disengage from said drive rod upon engagement of said latch mechanism, and a mechanical link between said slide frame and said piston of said suction generating means whereby said suction piston is moved within said suction piston cylinder when said pneumatically operated piston is actuated and generates a suction at said ampule when said pneumatically operated piston is driven in said second direction.
17. The needle free hypodermic injector of claim 13 further comprising a concave depression in said lower surface of said ampule surrounding and concentric with said suction port, whereby a suction generated by said suction generating means is applicable to said skin surface through said port whereby said skin surface is drawn against said lower surface of said ampule into said depression and against said jet orifice prior to injection of said medicament.
18. The needle free hypodermic injector of claim 17 wherein said jet orifice is located in said step face adjacent to an upper edge thereof and horizontally along a centerline of said bore whereby said ampule is adapted for intradermal injection of medicament.
19. The needle free hypodermic injector of claim 17 wherein said jet orifice is located in said step face at a downward angle relative to a centerline of said bore whereby said ampule is adapted for subcutaneous or intramuscular injection of medicament.
20. The needle free hypodermic injector of claim 11 wherein said ampule further comprises two suction ports laterally spaced on opposite sides of a center line of said ampule and extending vertically through said body from said upper surface to said lower surface at a point forward of said step face, said suction ports being in fluid communication with said suction generating means, said ampule further comprising a concave depression in said lower surface encompassing the lower ends of said suction ports, whereby a suction generated by said suction generating means is applicable to said skin surface through said ports whereby said skin surface is drawn against said lower surface of said ampule into said depression and against said jet orifice prior to injection of said medicament.
21. The needle free hypodermic injector of claim 14 wherein said at least one ampule comprises a multiple ampule assembly comprising a plurality of identical ampules arranged about and parallel to a center shaft in a cylindrical assembly, said cylindrical assembly being rotatable about said shaft for sequential registration of each ampule in said assembly with said drive rod and said suction conduits, said forward nose portion of said housing having a socket into which said center shaft is received, said socket and said shaft having cooperating detent means to removably secure said multiple ampule assembly to said injector housing, and said nose portion having detent means cooperable with said ampules to ensure accurate regisration of each of said ampules in turn with said drive rod and said suction conduits.
22. The needle free hypodermic injector of claim 14 wherein said at least one ampule further comprises a filling port disposed in said upper surface of said body, said filling port comprising a conduit providing fluid communication with the forward end of said chamber and a self sealing plug within said conduit adapted to receive a needle or probe of a filling syringe for injecting medicament into said chamber, said ampule further comprising a removable plug temporarily closing said jet orifice during filling and removable protective seals over said filing port, said removable plug and said open rearward end of said chamber.
23. The needle free hypodermic injector of claim 14 wherein said cocking means comprises an electrically actuated solenoid within said housing, a source of electrical power, electrical circuits, a trigger operated switch, a slide frame within said housing mechanically connected to said solenoid so as to reciprocate within said housing upon actuation of said solenoid, a drive rod latch attached to said slide frame and adapted to engage said drive rod when said solenoid is actuated in a first direction and to draw said drive rod rearward against the force of said compression drive spring when said solenoid is actuated in a second direction, said drive rod latch being biased to disengage from said drive rod upon engagement of said latch mechanism, and a mechanical link between said slide frame and said piston of said suction generating means whereby said suction piston is moved within said suction piston cylinder when said solenoid is actuated and generates a suction at said ampule when said pneumatically operated piston is driven in said second direction.
24. The needle free hypodermic injector of claim 14 wherein said drive rod is divided into two sections, a rear section with said compression drive spring concentric thereabout and a forward section adapted to enter said ampule, and a shock absorbing means uniting said front and rear sections, whereby said shock absorbing means operates to absorb the initial impact shock of release of said drive spring whereby the impulse of said drive rod against said ampule plunger is smooth and constant.
25. The needle free hypodermic injector of claim 4 wherein said drive rod is divided into two sections, a rear section with said compression drive spring concentric thereabout and a forward section adapted to enter said ampule, and a shock absorbing means uniting said front and rear sections, whereby said shock absorbing means operates to absorb the initial impact shock of release of said drive spring whereby the impulse of said drive rod against said ampule plunger is smooth and constant.
26. The needle free hypodermic injector of claim 3 wherein said impact impulse injection mechanism comprises:
a drive rod linearly reciprocatable within said housing between a cocked position and an injection position and having a forward portion adapted to project from said housing into said ampule bore to contact and drive said plunger upon movement of said drive rod from said cocked position to said injection position,
a pneumatic means reciprocating said drive rod between said cocked position and said injection position, and
a manually operated valve means actuating said pneumatic means,
whereby a first actuation of said pneumatic means draws said drive rod rearward in said housing allowing attachment of an ampule to said injector and a second actuation of said pneumatic means drives said drive rod forward to engage said plunger in said ampule and drive said plunger against said medicament whereby said medicament is forced through said orifice and injected into said skin surface.
27. The needle free hypodermic injector of claim 3 wherein said impact impulse injection mechanism comprises:
a drive rod linearly reciprocatable within said housing between a cocked position and an injection position and having a forward portion adapted to project from said housing into said ampule bore to contact and drive said plunger upon movement of said drive rod from said cocked position to said injection position,
a solenoid means reciprocating said drive rod between said cocked position and said injection position, and
a manually operated switch means actuating said solenoid means,
whereby a first actuation of said solenoid means draws said drive rod rearward in said housing allowing attachment of an ampule to said injector and a second actuation of said solenoid means drives said drive rod forward to engage said plunger in said ampule and drive said plunger against said medicament whereby said medicament is forced through said orifice and injected into said skin surface.
28. The needle free hypodermic injector of claim 6 wherein said cocking mechanism comprises a pneumatically actuated piston, a slide frame within said housing mechanically connected to said pneumatically actuated piston so as to reciprocate within said housing upon pneumatic actuation of said pneumatically actuated piston, valve means directing pneumatic fluid to said pneumatically actuated piston, a drive rod latch attached to said slide frame and adapted to engage said drive rod upon actuation of said piston, said drive rod latch being biased to disengage from said drive rod upon engagement of said releasable latch mechanism, and a mechanical link between said pneumatically actuated piston and said suction generating means whereby said suction generating means is actuated when said pneumatically actuated piston is actuated.
29. The needle free hypodermic injector of claim 6 wherein said cocking mechanism comprises an electrically actuated push-pull solenoid having a reciprocating core, a slide frame within said housing mechanically connected to said reciprocating core so as to reciprocate within said housing upon actuation of said solenoid, an electrical power source, switch means connecting said electrical power source and said solenoid operable to actuate said solenoid, a drive rod latch attached to said slide frame and adapted to engage said drive rod upon actuation of said solenoid, said drive rod latch being biased to disengage from said drive rod upon engagement of said releasable latch mechanism, and a mechanical link between said solenoid and said suction generating means whereby said suction generating means is actuated when said solenoid is actuated.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/555,742 US20070167907A1 (en) | 2002-11-20 | 2004-05-10 | Needle free hypodermic injector and ampule for intradermal, subcutaneous and intramuscular injection |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42770802P | 2002-11-20 | 2002-11-20 | |
US46944303P | 2003-05-09 | 2003-05-09 | |
US10/603,496 US6939319B1 (en) | 2002-11-20 | 2003-06-25 | Process and device for single use, needle-free intradermal, subcutaneous, or intramuscular injections |
US10/555,742 US20070167907A1 (en) | 2002-11-20 | 2004-05-10 | Needle free hypodermic injector and ampule for intradermal, subcutaneous and intramuscular injection |
PCT/US2004/014511 WO2004101025A2 (en) | 2003-05-09 | 2004-05-10 | Needle free hypodermic injector and ampule for intradermal, subcutaneous and intramuscular injection |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070167907A1 true US20070167907A1 (en) | 2007-07-19 |
Family
ID=34891108
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/603,496 Expired - Lifetime US6939319B1 (en) | 2002-11-20 | 2003-06-25 | Process and device for single use, needle-free intradermal, subcutaneous, or intramuscular injections |
US10/555,742 Abandoned US20070167907A1 (en) | 2002-11-20 | 2004-05-10 | Needle free hypodermic injector and ampule for intradermal, subcutaneous and intramuscular injection |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/603,496 Expired - Lifetime US6939319B1 (en) | 2002-11-20 | 2003-06-25 | Process and device for single use, needle-free intradermal, subcutaneous, or intramuscular injections |
Country Status (1)
Country | Link |
---|---|
US (2) | US6939319B1 (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080214995A1 (en) * | 2005-11-17 | 2008-09-04 | Zogenix, Inc. | Viscous formulations and their use in needle-free injection |
US20110082388A1 (en) * | 2008-07-09 | 2011-04-07 | Massachusetts Institute Of Technology | Bi-directional motion of a lorentz-force actuated needle-free injector (nfi) |
US20120209191A1 (en) * | 2006-02-09 | 2012-08-16 | Gray Larry B | Adhesive and peripheral systems and methods for medical devices |
US20130150820A1 (en) * | 2011-12-13 | 2013-06-13 | Pharmajet Inc. | Needle-free intradermal injection device |
ITMI20132067A1 (en) * | 2013-12-11 | 2015-06-12 | Dante Lorini | EQUIPMENT FOR THE TRANSDERMIC INOCULATION OF MEDICINATIONS |
US9408972B2 (en) | 2011-08-02 | 2016-08-09 | Pharmajet, Inc. | Needle-free injection device |
US9446200B2 (en) | 2008-12-09 | 2016-09-20 | Becton, Dickinson And Company | Lever and gear force multiplier medication delivery system for high pressure injection system |
US10653842B2 (en) | 2015-08-18 | 2020-05-19 | Daicel Corporation | Needleless syringe |
US10722655B2 (en) | 2014-05-07 | 2020-07-28 | Amgen Inc. | Autoinjector with shock reducing elements |
CN111616796A (en) * | 2014-09-15 | 2020-09-04 | 诺服塞尔有限公司 | Method and apparatus for thermal tissue vaporization and compression |
WO2020205615A1 (en) * | 2019-03-29 | 2020-10-08 | Aijex Pharma International, Inc. | Needleless injector and related methods |
CN111918684A (en) * | 2018-03-26 | 2020-11-10 | 英特维特国际股份有限公司 | Device for administering a fluid |
CN111936185A (en) * | 2018-03-26 | 2020-11-13 | 英特维特国际股份有限公司 | Device for administering a fluid |
US11134896B2 (en) | 2017-06-23 | 2021-10-05 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11160926B1 (en) | 2007-10-09 | 2021-11-02 | Dexcom, Inc. | Pre-connected analyte sensors |
US11166657B2 (en) | 2015-12-30 | 2021-11-09 | Dexcom, Inc. | Transcutaneous analyte sensor systems and methods |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US11350862B2 (en) | 2017-10-24 | 2022-06-07 | Dexcom, Inc. | Pre-connected analyte sensors |
US11627900B2 (en) | 2003-12-05 | 2023-04-18 | Dexcom, Inc. | Analyte sensor |
US11904143B2 (en) | 2017-06-08 | 2024-02-20 | Amgen Inc. | Torque driven drug delivery device |
US12029882B2 (en) | 2020-06-19 | 2024-07-09 | Amgen Inc. | Autoinjector with shock reducing elements |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0206560D0 (en) | 2002-03-20 | 2002-05-01 | Glaxo Group Ltd | Novel device |
EP1689465A4 (en) * | 2003-12-05 | 2011-10-12 | Zogenix Inc | A device for readying a needle free injector for delivery |
GB2414409B (en) | 2004-05-28 | 2009-11-18 | Cilag Ag Int | Injection device |
GB2414400B (en) | 2004-05-28 | 2009-01-14 | Cilag Ag Int | Injection device |
GB2414775B (en) | 2004-05-28 | 2008-05-21 | Cilag Ag Int | Releasable coupling and injection device |
GB2414402B (en) | 2004-05-28 | 2009-04-22 | Cilag Ag Int | Injection device |
GB2414406B (en) * | 2004-05-28 | 2009-03-18 | Cilag Ag Int | Injection device |
GB2414401B (en) | 2004-05-28 | 2009-06-17 | Cilag Ag Int | Injection device |
GB2414403B (en) * | 2004-05-28 | 2009-01-07 | Cilag Ag Int | Injection device |
GB2414399B (en) | 2004-05-28 | 2008-12-31 | Cilag Ag Int | Injection device |
GB2424835B (en) | 2005-04-06 | 2010-06-09 | Cilag Ag Int | Injection device (modified trigger) |
GB2424838B (en) | 2005-04-06 | 2011-02-23 | Cilag Ag Int | Injection device (adaptable drive) |
GB2427826B (en) | 2005-04-06 | 2010-08-25 | Cilag Ag Int | Injection device comprising a locking mechanism associated with integrally formed biasing means |
GB2424836B (en) | 2005-04-06 | 2010-09-22 | Cilag Ag Int | Injection device (bayonet cap removal) |
GB2425062B (en) | 2005-04-06 | 2010-07-21 | Cilag Ag Int | Injection device |
ES2852648T3 (en) | 2005-05-06 | 2021-09-14 | Instr Laboratory Co | Telescopic closed tube sampling set |
ATE452670T1 (en) | 2005-08-30 | 2010-01-15 | Cilag Gmbh Int | NEEDLE DEVICE FOR A PREFILLED SYRINGE |
US20110098656A1 (en) | 2005-09-27 | 2011-04-28 | Burnell Rosie L | Auto-injection device with needle protecting cap having outer and inner sleeves |
GB2438593B (en) | 2006-06-01 | 2011-03-30 | Cilag Gmbh Int | Injection device (cap removal feature) |
GB2438591B (en) | 2006-06-01 | 2011-07-13 | Cilag Gmbh Int | Injection device |
GB2438590B (en) | 2006-06-01 | 2011-02-09 | Cilag Gmbh Int | Injection device |
US9662440B2 (en) * | 2006-12-22 | 2017-05-30 | Roche Diabetes Care, Inc. | Systems, devices and methods for sustained delivery of a therapeutic fluid |
GB2461086B (en) | 2008-06-19 | 2012-12-05 | Cilag Gmbh Int | Injection device |
GB2461084B (en) | 2008-06-19 | 2012-09-26 | Cilag Gmbh Int | Fluid transfer assembly |
GB2461087B (en) | 2008-06-19 | 2012-09-26 | Cilag Gmbh Int | Injection device |
GB2461085B (en) | 2008-06-19 | 2012-08-29 | Cilag Gmbh Int | Injection device |
GB2461089B (en) | 2008-06-19 | 2012-09-19 | Cilag Gmbh Int | Injection device |
US8130904B2 (en) | 2009-01-29 | 2012-03-06 | The Invention Science Fund I, Llc | Diagnostic delivery service |
US8111809B2 (en) | 2009-01-29 | 2012-02-07 | The Invention Science Fund I, Llc | Diagnostic delivery service |
JP2013517081A (en) * | 2010-01-19 | 2013-05-16 | ケンブリッジ・エンタープライズ・リミテッド | Apparatus and method |
EP2399634A1 (en) * | 2010-06-28 | 2011-12-28 | Sanofi-Aventis Deutschland GmbH | Needle safety arrangement and method for operating it |
GB2488579A (en) * | 2011-03-02 | 2012-09-05 | Owen Mumford Ltd | Autoinjector with "injection complete" indicator |
US20120226527A1 (en) * | 2011-03-02 | 2012-09-06 | Bank Of America Corporation | Centralized customer contact database |
US9386713B1 (en) * | 2014-12-31 | 2016-07-05 | International Business Machines Corporation | Modular elements employing latches secured by linkages |
CA2837367A1 (en) | 2011-04-29 | 2012-11-01 | Baylor College Of Medicine | Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection |
CA2860711A1 (en) * | 2012-01-06 | 2013-07-11 | Svw Technologies Pty Ltd | Method and apparatus for castration of animals |
GB2515032A (en) | 2013-06-11 | 2014-12-17 | Cilag Gmbh Int | Guide for an injection device |
GB2517896B (en) | 2013-06-11 | 2015-07-08 | Cilag Gmbh Int | Injection device |
GB2515039B (en) | 2013-06-11 | 2015-05-27 | Cilag Gmbh Int | Injection Device |
GB2515038A (en) | 2013-06-11 | 2014-12-17 | Cilag Gmbh Int | Injection device |
US9497871B2 (en) | 2014-12-19 | 2016-11-15 | International Business Machines Corporation | Modular enclosure elements employing cams forming detent features with latches |
US9686883B2 (en) | 2014-12-29 | 2017-06-20 | International Business Machines Corporation | Modular elements employing latches with flexure bearings |
IL239366B (en) * | 2015-06-11 | 2018-07-31 | Kriheli Marino | Components of a fluid transfer apparatus |
DE102018107103A1 (en) * | 2018-03-26 | 2019-09-26 | Henke-Sass, Wolf Gmbh | Device for applying a fluid |
CN108995832B (en) * | 2018-07-26 | 2021-05-28 | 西安航天动力技术研究所 | Pneumatic booster-type interstage separation mechanism |
CN113325927B (en) * | 2020-02-28 | 2023-09-22 | 富联精密电子(天津)有限公司 | Fixing device and chassis with same |
CN113425999B (en) * | 2021-07-14 | 2022-08-30 | 新疆维吾尔自治区人民医院 | Ear-nose-throat drug delivery device not prone to blockage |
CN114917431A (en) * | 2022-05-17 | 2022-08-19 | 北京快舒尔医疗技术有限公司 | Syringe body and syringe having the same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3859996A (en) * | 1973-07-18 | 1975-01-14 | Mizzy Inc | Multi-dose injector |
US5480381A (en) * | 1991-08-23 | 1996-01-02 | Weston Medical Limited | Needle-less injector |
US5891086A (en) * | 1993-07-31 | 1999-04-06 | Weston Medical Limited | Needle-less injector |
US6406456B1 (en) * | 2000-06-08 | 2002-06-18 | Avant Drug Delivery Systems, Inc. | Jet injector |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5062830A (en) * | 1990-04-04 | 1991-11-05 | Derata Corporation | Dry disposable nozzle assembly for medical jet injector |
US5911703A (en) * | 1997-05-22 | 1999-06-15 | Avant Drug Delivery Systems, Inc. | Two-stage fluid medicament jet injector |
US6689092B2 (en) * | 2000-03-03 | 2004-02-10 | Boehringer International Gmbh | Needle-less injector of miniature type |
US6652483B2 (en) * | 2000-11-07 | 2003-11-25 | Avant Drug Delivery Systems, Inc. | Needleless jet injector system with separate drug reservoir |
US6817986B2 (en) * | 2001-04-13 | 2004-11-16 | Avant Medical Corp. | Jet injector with data logging system for use in compliance and dose monitoring programs |
-
2003
- 2003-06-25 US US10/603,496 patent/US6939319B1/en not_active Expired - Lifetime
-
2004
- 2004-05-10 US US10/555,742 patent/US20070167907A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3859996A (en) * | 1973-07-18 | 1975-01-14 | Mizzy Inc | Multi-dose injector |
US5480381A (en) * | 1991-08-23 | 1996-01-02 | Weston Medical Limited | Needle-less injector |
US5891086A (en) * | 1993-07-31 | 1999-04-06 | Weston Medical Limited | Needle-less injector |
US6406456B1 (en) * | 2000-06-08 | 2002-06-18 | Avant Drug Delivery Systems, Inc. | Jet injector |
Cited By (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11627900B2 (en) | 2003-12-05 | 2023-04-18 | Dexcom, Inc. | Analyte sensor |
US20080214995A1 (en) * | 2005-11-17 | 2008-09-04 | Zogenix, Inc. | Viscous formulations and their use in needle-free injection |
US9186461B2 (en) | 2005-11-17 | 2015-11-17 | Zogenix, Inc. | Viscous formulations and their use in needle-free injection |
US20110196336A1 (en) * | 2005-11-17 | 2011-08-11 | Zogenix, Inc. | Viscous formulations and their use in needle-free injection |
US8066661B2 (en) * | 2005-11-17 | 2011-11-29 | Zogenix, Inc. | Viscous formulations and their use in needle-free injection |
US8876758B2 (en) | 2005-11-17 | 2014-11-04 | Zogenix, Inc. | Viscous formulations and their use in needle-free injection |
US20120209191A1 (en) * | 2006-02-09 | 2012-08-16 | Gray Larry B | Adhesive and peripheral systems and methods for medical devices |
US8435214B2 (en) * | 2006-02-09 | 2013-05-07 | Deka Products Limited Partnership | Adhesive and peripheral systems and methods for medical devices |
US10835669B2 (en) | 2006-02-09 | 2020-11-17 | Deka Products Limited Partnership | Adhesive and peripheral systems and methods for medical devices |
US11408414B2 (en) | 2006-02-09 | 2022-08-09 | Deka Products Limited Partnership | Adhesive and peripheral systems and methods for medical devices |
US11160926B1 (en) | 2007-10-09 | 2021-11-02 | Dexcom, Inc. | Pre-connected analyte sensors |
US11571519B2 (en) | 2008-07-09 | 2023-02-07 | Massachusetts Institute Of Technology | Bi-directional motion of a Lorentz-force actuated needle-free injector (NFI) |
US8398583B2 (en) | 2008-07-09 | 2013-03-19 | Massachusetts Institute Of Technology | Method and apparatus for extraction of a sample from a sample source |
US10485928B2 (en) | 2008-07-09 | 2019-11-26 | Massachusetts Institute Of Technology | Bi-directional motion of a Lorentz-force actuated needle-free injector (NFI) |
US9125990B2 (en) * | 2008-07-09 | 2015-09-08 | Massachusetts Institute Of Technology | Bi-directional motion of a lorentz-force actuated needle-free injector (NFI) |
US20110166549A1 (en) * | 2008-07-09 | 2011-07-07 | Massachusetts Institute Of Technology | Bi-directional motion of a lorentz-force actuated needle-free injector (nfi) |
US20110082388A1 (en) * | 2008-07-09 | 2011-04-07 | Massachusetts Institute Of Technology | Bi-directional motion of a lorentz-force actuated needle-free injector (nfi) |
US9789256B2 (en) | 2008-07-09 | 2017-10-17 | Massachusetts Institute Of Technology | Bi-directional motion of a lorentz-force actuated needle-free injector (NFI) |
US9446200B2 (en) | 2008-12-09 | 2016-09-20 | Becton, Dickinson And Company | Lever and gear force multiplier medication delivery system for high pressure injection system |
US10213553B2 (en) | 2008-12-09 | 2019-02-26 | Becton, Dickinson And Company | Lever and gear force multiplier medication delivery system for high pressure injection system |
US9408972B2 (en) | 2011-08-02 | 2016-08-09 | Pharmajet, Inc. | Needle-free injection device |
US10463795B2 (en) | 2011-08-02 | 2019-11-05 | Pharmajet Inc. | Needle-free injection methods |
US11471603B2 (en) | 2011-08-02 | 2022-10-18 | Pharmajet, Inc. | Needle-free injector |
US10322238B2 (en) | 2011-12-13 | 2019-06-18 | Pharmajet, Inc. | Needle-free intradermal injection device |
US20130150820A1 (en) * | 2011-12-13 | 2013-06-13 | Pharmajet Inc. | Needle-free intradermal injection device |
US9700675B2 (en) | 2011-12-13 | 2017-07-11 | Pharmajet Inc. | Needle-free intradermal injection device |
US9433735B2 (en) * | 2011-12-13 | 2016-09-06 | Pharmajet Inc. | Needle-free intradermal injection device |
US11154659B2 (en) | 2011-12-13 | 2021-10-26 | Pharmajet Inc. | Needle-free intradermal injection device |
KR102102176B1 (en) * | 2011-12-13 | 2020-04-21 | 파마젯 인코포레이티드 | Needle-free intradermal injection device |
JP2015500131A (en) * | 2011-12-13 | 2015-01-05 | ファーマジェット・インコーポレイテッドPharmaJet, Inc. | Needleless intradermal injection device |
EP3925651A1 (en) * | 2011-12-13 | 2021-12-22 | Pharmajet Inc. | Needle-free intradermal injection device |
KR20140105756A (en) * | 2011-12-13 | 2014-09-02 | 파마젯 인코포레이티드 | Needle-free intradermal injection device |
CN103998081A (en) * | 2011-12-13 | 2014-08-20 | 医用注射器公司 | Needle-free intradermal injection device |
RU2627632C2 (en) * | 2011-12-13 | 2017-08-09 | Фармаджет Инк. | Needle-free intradermal injection device |
WO2013090315A1 (en) | 2011-12-13 | 2013-06-20 | Pharmajet Inc. | Needle-free intradermal injection device |
ITMI20132067A1 (en) * | 2013-12-11 | 2015-06-12 | Dante Lorini | EQUIPMENT FOR THE TRANSDERMIC INOCULATION OF MEDICINATIONS |
EP2896420A1 (en) * | 2013-12-11 | 2015-07-22 | Dante Lorini | Apparatus for needleless transdermal inoculation of medicaments |
US10722655B2 (en) | 2014-05-07 | 2020-07-28 | Amgen Inc. | Autoinjector with shock reducing elements |
CN111616796A (en) * | 2014-09-15 | 2020-09-04 | 诺服塞尔有限公司 | Method and apparatus for thermal tissue vaporization and compression |
US10653842B2 (en) | 2015-08-18 | 2020-05-19 | Daicel Corporation | Needleless syringe |
US11331021B2 (en) | 2015-12-30 | 2022-05-17 | Dexcom, Inc. | Transcutaneous analyte sensor systems and methods |
US11375932B2 (en) | 2015-12-30 | 2022-07-05 | Dexcom, Inc. | Transcutaneous analyte sensor systems and methods |
US11412966B2 (en) | 2015-12-30 | 2022-08-16 | Dexcom, Inc. | Transcutaneous analyte sensor systems and methods |
US11602291B2 (en) | 2015-12-30 | 2023-03-14 | Dexcom, Inc. | Transcutaneous analyte sensor systems and methods |
US11642055B2 (en) | 2015-12-30 | 2023-05-09 | Dexcom, Inc. | Transcutaneous analyte sensor systems and methods |
US11166657B2 (en) | 2015-12-30 | 2021-11-09 | Dexcom, Inc. | Transcutaneous analyte sensor systems and methods |
US11904143B2 (en) | 2017-06-08 | 2024-02-20 | Amgen Inc. | Torque driven drug delivery device |
US11207026B2 (en) | 2017-06-23 | 2021-12-28 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11510625B2 (en) | 2017-06-23 | 2022-11-29 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11134896B2 (en) | 2017-06-23 | 2021-10-05 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11311241B2 (en) | 2017-06-23 | 2022-04-26 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11311240B2 (en) | 2017-06-23 | 2022-04-26 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11395631B2 (en) | 2017-06-23 | 2022-07-26 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11504063B2 (en) | 2017-06-23 | 2022-11-22 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11350862B2 (en) | 2017-10-24 | 2022-06-07 | Dexcom, Inc. | Pre-connected analyte sensors |
US11382540B2 (en) | 2017-10-24 | 2022-07-12 | Dexcom, Inc. | Pre-connected analyte sensors |
US11706876B2 (en) | 2017-10-24 | 2023-07-18 | Dexcom, Inc. | Pre-connected analyte sensors |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US11943876B2 (en) | 2017-10-24 | 2024-03-26 | Dexcom, Inc. | Pre-connected analyte sensors |
CN111918684A (en) * | 2018-03-26 | 2020-11-10 | 英特维特国际股份有限公司 | Device for administering a fluid |
CN111936185A (en) * | 2018-03-26 | 2020-11-13 | 英特维特国际股份有限公司 | Device for administering a fluid |
WO2020205615A1 (en) * | 2019-03-29 | 2020-10-08 | Aijex Pharma International, Inc. | Needleless injector and related methods |
US12029882B2 (en) | 2020-06-19 | 2024-07-09 | Amgen Inc. | Autoinjector with shock reducing elements |
Also Published As
Publication number | Publication date |
---|---|
US6939319B1 (en) | 2005-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070167907A1 (en) | Needle free hypodermic injector and ampule for intradermal, subcutaneous and intramuscular injection | |
WO2004101025A2 (en) | Needle free hypodermic injector and ampule for intradermal, subcutaneous and intramuscular injection | |
US7060054B2 (en) | Suction piece for or on a device administering an injectable product | |
US11723840B2 (en) | Intradermal injection device | |
CA2140772C (en) | Needleless hypodermic injection methods and device | |
RU2179864C2 (en) | Needleless injector | |
US4447225A (en) | Multidose jet injector | |
US5217442A (en) | Aspiration and refill kit for a medication infusion pump | |
US6506177B2 (en) | Needle-less injection system | |
JP3816842B2 (en) | Needleless jet infusion system with separate drug reservoir | |
JP3213008B2 (en) | Jet hypodermic injection device | |
WO1994002188A9 (en) | Needleless hypodermic injection methods and device | |
US20090105685A1 (en) | Two Stage Jet Injection Device | |
US20040159364A1 (en) | Needle-free injection system | |
JP6317676B2 (en) | Needleless intradermal injection device | |
JP2005517500A (en) | Syringe with bypass channel | |
JP2006516919A (en) | Needleless mass injection device | |
JP2015500131A5 (en) | ||
JP2001346878A (en) | Jetting type medicinal liquid-injecting device | |
EP1514565A1 (en) | Sequential impulse / Delivery fluid medicament injector | |
CN218852891U (en) | Needleless injector | |
EP3710088B1 (en) | Device and mixing and/or reconstitution method | |
JP7264558B1 (en) | needle-free syringe | |
US20220409816A1 (en) | Needleless injectors and related methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |